KR20180045658A - Solid fermented soybean with mushroom and method for preparation thereof - Google Patents
Solid fermented soybean with mushroom and method for preparation thereof Download PDFInfo
- Publication number
- KR20180045658A KR20180045658A KR1020160140273A KR20160140273A KR20180045658A KR 20180045658 A KR20180045658 A KR 20180045658A KR 1020160140273 A KR1020160140273 A KR 1020160140273A KR 20160140273 A KR20160140273 A KR 20160140273A KR 20180045658 A KR20180045658 A KR 20180045658A
- Authority
- KR
- South Korea
- Prior art keywords
- mushroom
- soybean
- fermented
- powder
- present
- Prior art date
Links
- 235000010469 Glycine max Nutrition 0.000 title claims abstract description 204
- 244000068988 Glycine max Species 0.000 title claims abstract description 203
- 235000001674 Agaricus brunnescens Nutrition 0.000 title claims abstract description 148
- 238000000034 method Methods 0.000 title claims description 36
- 239000007787 solid Substances 0.000 title claims description 27
- 238000002360 preparation method Methods 0.000 title description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims abstract description 58
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 claims abstract description 56
- 229940108924 conjugated linoleic acid Drugs 0.000 claims abstract description 53
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims abstract description 48
- 229910021529 ammonia Inorganic materials 0.000 claims abstract description 26
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 17
- 230000001965 increasing effect Effects 0.000 claims abstract description 15
- 239000000796 flavoring agent Substances 0.000 claims abstract description 14
- 235000019634 flavors Nutrition 0.000 claims abstract description 14
- 241000121220 Tricholoma matsutake Species 0.000 claims abstract description 10
- 208000008589 Obesity Diseases 0.000 claims abstract description 9
- 206010012601 diabetes mellitus Diseases 0.000 claims abstract description 9
- 235000020824 obesity Nutrition 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims description 103
- 238000000855 fermentation Methods 0.000 claims description 72
- 230000004151 fermentation Effects 0.000 claims description 72
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 37
- 235000008696 isoflavones Nutrition 0.000 claims description 37
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 31
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 31
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 claims description 28
- 150000002338 glycosides Chemical class 0.000 claims description 25
- 229930182470 glycoside Natural products 0.000 claims description 24
- 235000013305 food Nutrition 0.000 claims description 17
- 241001137251 Corvidae Species 0.000 claims description 16
- 238000001035 drying Methods 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 9
- 239000006187 pill Substances 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- 238000002791 soaking Methods 0.000 claims description 7
- 239000000499 gel Substances 0.000 claims description 6
- 235000015110 jellies Nutrition 0.000 claims description 6
- 239000008274 jelly Substances 0.000 claims description 6
- 239000006188 syrup Substances 0.000 claims description 6
- 235000020357 syrup Nutrition 0.000 claims description 6
- 238000011081 inoculation Methods 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 238000010899 nucleation Methods 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 abstract description 26
- 235000013376 functional food Nutrition 0.000 abstract description 5
- 240000001080 Grifola frondosa Species 0.000 abstract description 2
- 235000007710 Grifola frondosa Nutrition 0.000 abstract description 2
- 241000769240 Polyozellus multiplex Species 0.000 abstract description 2
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 52
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 230000000694 effects Effects 0.000 description 19
- 230000000052 comparative effect Effects 0.000 description 18
- 235000014113 dietary fatty acids Nutrition 0.000 description 18
- 229930195729 fatty acid Natural products 0.000 description 18
- 239000000194 fatty acid Substances 0.000 description 18
- 150000004665 fatty acids Chemical class 0.000 description 17
- 230000002292 Radical scavenging effect Effects 0.000 description 16
- 235000001014 amino acid Nutrition 0.000 description 16
- 229940024606 amino acid Drugs 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 238000004458 analytical method Methods 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 14
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 13
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 12
- 150000001413 amino acids Chemical class 0.000 description 12
- 229960004488 linolenic acid Drugs 0.000 description 12
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 235000013527 bean curd Nutrition 0.000 description 11
- 235000013322 soy milk Nutrition 0.000 description 11
- 239000000284 extract Substances 0.000 description 10
- 230000002401 inhibitory effect Effects 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 238000002835 absorbance Methods 0.000 description 9
- 108010083364 chungkookjang Proteins 0.000 description 9
- 150000002515 isoflavone derivatives Chemical class 0.000 description 9
- 240000000599 Lentinula edodes Species 0.000 description 8
- 240000007594 Oryza sativa Species 0.000 description 8
- 235000007164 Oryza sativa Nutrition 0.000 description 8
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 8
- 235000013824 polyphenols Nutrition 0.000 description 8
- 235000009566 rice Nutrition 0.000 description 8
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 230000035784 germination Effects 0.000 description 7
- 235000019645 odor Nutrition 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 239000013642 negative control Substances 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 244000063299 Bacillus subtilis Species 0.000 description 5
- 235000014469 Bacillus subtilis Nutrition 0.000 description 5
- 241000233866 Fungi Species 0.000 description 5
- 230000001093 anti-cancer Effects 0.000 description 5
- 102000038379 digestive enzymes Human genes 0.000 description 5
- 108091007734 digestive enzymes Proteins 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 235000019629 palatability Nutrition 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 241000287456 Laniidae Species 0.000 description 4
- 102000019280 Pancreatic lipases Human genes 0.000 description 4
- 108050006759 Pancreatic lipases Proteins 0.000 description 4
- 108010028144 alpha-Glucosidases Proteins 0.000 description 4
- -1 ammonia amino acid Chemical class 0.000 description 4
- 235000008429 bread Nutrition 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 235000021107 fermented food Nutrition 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 229940116369 pancreatic lipase Drugs 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000012064 sodium phosphate buffer Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 3
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 235000020778 linoleic acid Nutrition 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QCHPKSFMDHPSNR-UHFFFAOYSA-N 3-aminoisobutyric acid Chemical compound NCC(C)C(O)=O QCHPKSFMDHPSNR-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 235000007516 Chrysanthemum Nutrition 0.000 description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 240000006055 Dacrydium cupressinum Species 0.000 description 2
- 235000018782 Dacrydium cupressinum Nutrition 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 2
- 235000013697 Pinus resinosa Nutrition 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- AHANXAKGNAKFSK-PDBXOOCHSA-N all-cis-icosa-11,14,17-trienoic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCCCC(O)=O AHANXAKGNAKFSK-PDBXOOCHSA-N 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- PRHHYVQTPBEDFE-UHFFFAOYSA-N eicosatrienoic acid Natural products CCCCCC=CCC=CCCCCC=CCCCC(O)=O PRHHYVQTPBEDFE-UHFFFAOYSA-N 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 2
- OZBAVEKZGSOMOJ-MIUGBVLSSA-N glycitin Chemical compound COC1=CC(C(C(C=2C=CC(O)=CC=2)=CO2)=O)=C2C=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O OZBAVEKZGSOMOJ-MIUGBVLSSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- XSXIVVZCUAHUJO-AVQMFFATSA-N (11e,14e)-icosa-11,14-dienoic acid Chemical compound CCCCC\C=C\C\C=C\CCCCCCCCCC(O)=O XSXIVVZCUAHUJO-AVQMFFATSA-N 0.000 description 1
- GWHCXVQVJPWHRF-KTKRTIGZSA-N (15Z)-tetracosenoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- QWCKQJZIFLGMSD-UHFFFAOYSA-N 2-Aminobutanoic acid Natural products CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- OYIFNHCXNCRBQI-UHFFFAOYSA-N 2-aminoadipic acid Chemical compound OC(=O)C(N)CCCC(O)=O OYIFNHCXNCRBQI-UHFFFAOYSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 1
- BRMWTNUJHUMWMS-UHFFFAOYSA-N 3-Methylhistidine Natural products CN1C=NC(CC(N)C(O)=O)=C1 BRMWTNUJHUMWMS-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- 244000066764 Ailanthus triphysa Species 0.000 description 1
- 108010085443 Anserine Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 1
- 108010087806 Carnosine Proteins 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 240000005109 Cryptomeria japonica Species 0.000 description 1
- QWCKQJZIFLGMSD-GSVOUGTGSA-N D-alpha-aminobutyric acid Chemical compound CC[C@@H](N)C(O)=O QWCKQJZIFLGMSD-GSVOUGTGSA-N 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- 101000874334 Dalbergia nigrescens Isoflavonoid 7-O-beta-apiosyl-glucoside beta-glycosidase Proteins 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 235000021297 Eicosadienoic acid Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 101000757733 Enterococcus faecalis (strain ATCC 700802 / V583) Autolysin Proteins 0.000 description 1
- ZCOLJUOHXJRHDI-FZHKGVQDSA-N Genistein 7-O-glucoside Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)c1cc(O)c2C(=O)C(c3ccc(O)cc3)=COc2c1 ZCOLJUOHXJRHDI-FZHKGVQDSA-N 0.000 description 1
- CJPNHKPXZYYCME-UHFFFAOYSA-N Genistin Natural products OCC1OC(Oc2ccc(O)c3OC(=CC(=O)c23)c4ccc(O)cc4)C(O)C(O)C1O CJPNHKPXZYYCME-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- XJTZHGNBKZYODI-UHFFFAOYSA-N Glycitin Natural products OCC1OC(Oc2ccc3OC=C(C(=O)c3c2CO)c4ccc(O)cc4)C(O)C(O)C1O XJTZHGNBKZYODI-UHFFFAOYSA-N 0.000 description 1
- 108700023372 Glycosyltransferases Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- SLRNWACWRVGMKD-UHFFFAOYSA-N L-anserine Natural products CN1C=NC(CC(NC(=O)CCN)C(O)=O)=C1 SLRNWACWRVGMKD-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 235000021353 Lignoceric acid Nutrition 0.000 description 1
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 101000757734 Mycolicibacterium phlei 38 kDa autolysin Proteins 0.000 description 1
- JDHILDINMRGULE-LURJTMIESA-N N(pros)-methyl-L-histidine Chemical compound CN1C=NC=C1C[C@H](N)C(O)=O JDHILDINMRGULE-LURJTMIESA-N 0.000 description 1
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- XJXROGWVRIJYMO-SJDLZYGOSA-N Nervonic acid Natural products O=C(O)[C@@H](/C=C/CCCCCCCC)CCCCCCCCCCCC XJXROGWVRIJYMO-SJDLZYGOSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000266501 Ormosia ormondii Species 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- YCUNGEJJOMKCGZ-UHFFFAOYSA-N Pallidiflorin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC(O)=C2C1=O YCUNGEJJOMKCGZ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 241000210053 Potentilla elegans Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- ZTOJFFHGPLIVKC-CLFAGFIQSA-N abts Chemical compound S/1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C\1=N\N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-CLFAGFIQSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- MYYIAHXIVFADCU-QMMMGPOBSA-N anserine Chemical compound CN1C=NC=C1C[C@H](NC(=O)CC[NH3+])C([O-])=O MYYIAHXIVFADCU-QMMMGPOBSA-N 0.000 description 1
- 229940124650 anti-cancer therapies Drugs 0.000 description 1
- 230000005904 anticancer immunity Effects 0.000 description 1
- 238000011319 anticancer therapy Methods 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013614 black pepper Nutrition 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- GWHCXVQVJPWHRF-UHFFFAOYSA-N cis-tetracosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-UHFFFAOYSA-N 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000008162 cooking oil Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- FARYTWBWLZAXNK-WAYWQWQTSA-N ethyl (z)-3-(methylamino)but-2-enoate Chemical compound CCOC(=O)\C=C(\C)NC FARYTWBWLZAXNK-WAYWQWQTSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 244000144992 flock Species 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 229940045109 genistein Drugs 0.000 description 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
- 235000006539 genistein Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- NNUVCMKMNCKPKN-UHFFFAOYSA-N glycitein Natural products COc1c(O)ccc2OC=C(C(=O)c12)c3ccc(O)cc3 NNUVCMKMNCKPKN-UHFFFAOYSA-N 0.000 description 1
- 235000008466 glycitein Nutrition 0.000 description 1
- DXYUAIFZCFRPTH-UHFFFAOYSA-N glycitein Chemical compound C1=C(O)C(OC)=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 DXYUAIFZCFRPTH-UHFFFAOYSA-N 0.000 description 1
- 102000045442 glycosyltransferase activity proteins Human genes 0.000 description 1
- 108700014210 glycosyltransferase activity proteins Proteins 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229940071264 lithium citrate Drugs 0.000 description 1
- WJSIUCDMWSDDCE-UHFFFAOYSA-K lithium citrate (anhydrous) Chemical compound [Li+].[Li+].[Li+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WJSIUCDMWSDDCE-UHFFFAOYSA-K 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- DVDUMIQZEUTAGK-UHFFFAOYSA-N p-nitrophenyl butyrate Chemical compound CCCC(=O)OC1=CC=C([N+]([O-])=O)C=C1 DVDUMIQZEUTAGK-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 235000014594 pastries Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000004767 rumen Anatomy 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/50—Fermented pulses or legumes; Fermentation of pulses or legumes based on the addition of microorganisms
-
- A23L11/09—
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/30—Removing undesirable substances, e.g. bitter substances
- A23L11/37—Removing undesirable substances, e.g. bitter substances using microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/40—Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/18—Lipids
- A23V2250/186—Fatty acids
- A23V2250/1866—Conjugated Linoleic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/208—Fungi extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2116—Flavonoids, isoflavones
- A23V2250/21172—Soy Isoflavones, daidzein, genistein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Health & Medical Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Beans For Foods Or Fodder (AREA)
Abstract
Description
본 발명은 버섯에 의해 고체 발효된 콩발효물 및 이의 제조방법에 관한 것이다. 보다 상세하게 본 발명은 공액리놀레산 및 비배당체-이소플라빈이 증진되고, 암모니아 함량이 감소하고 풍미가 개선된 버섯에 의해 고체 발효된 콩발효물 및 이의 제조방법에 관한 것이다.The present invention relates to soybean fermented by solid fermentation by mushroom and a method for producing the same. More specifically, the present invention relates to a soybean fermented product obtained by solid-fermenting mushroom with improved conjugated linoleic acid and non-glycoside-isoflavin, reduced ammonia content and improved flavor, and a process for producing the same.
콩[Glycine max (L.) Merrill]은 한반도 북부 및 만주일대가 원산지로 오랫동안 우리 식생활에서 쌀 다음으로, 중요한 부분을 차지하여 왔다. 쌀, 보리 등 곡류를 주식으로 하는 우리나라 밥상에서 콩은 단백질과 지방의 급원으로 매우 중요한 역할을 해왔다. 특히 콩은 한국 사람이 끼니때마다 접하게 되는 된장, 간장, 고추장 및 청국장의 주원료이며, 두유, 두부 및 식용유 등 가공제품의 원료로 그 사용 빈도가 매우 높은 식용작물이다.Soybean [ Glycine max (L.) Merrill ] has been an important part of our diet for a long time, after rice and rice, originating in the northern part of the Korean Peninsula and Manchuria. Soybean has played a very important role as a source of protein and fat in the Korean rice dish, which is made from grains such as rice and barley. Especially, soybean is the main ingredient of soybean paste, soybean paste, kochujang, and chungkukjang, which is frequently used by Korean people. It is an edible crop that is used frequently as a raw material for processed products such as soybean milk, tofu and cooking oil.
또한, 버섯은 균류 중에서 육안으로 식별할 수 있는 크기의 자실체를 형성하는 무리의 총칭으로 정의된다. 이들은 당질, 지질, 단백질, 무기질 및 비타민 등의 영양소가 골고루 함유되어 있고 독특한 질감과 향을 가지고 있는 것이 특징이며 식용 및 약용으로 이용되고 있는 식품이다. 많은 담자균류의 균사체 및 자실체는 여러 항암 효과와 면역 증강이 있는 것으로 보고되어 있다. 담자균류의 균사체는 일반적으로 사용되는 항암치료제와는 달리 특별한 부작용이 없고 면역 기능을 증대시켜 항암 효과를 나타낸다는 점이 최대의 장점이라 할 수 있다.In addition, mushroom is defined as a generic name of a flock that forms visually identifiable fruiting bodies among fungi. They are composed of various nutrients such as carbohydrates, lipids, proteins, minerals and vitamins. They are characterized by their unique texture and fragrance. They are used for edible and medicinal purposes. Many mycelium and fruiting bodies of bacterium have been reported to have various anti-cancer effects and immunity enhancement. Mycelium of basidiomycetes does not have any side effects unlike the commonly used anticancer therapies, and it has the greatest advantage of enhancing immune function and exhibiting anticancer effect.
한편, 공액리놀레산(Conjugated Linoleic Acid; CLA)은 리놀레산의 이성질체로 공액 이중결합 구조를 가진다. 리놀레산은 9번과 12번 탄소에서 cis 형태의 이중결합을 갖는데 반하여, 공액리놀레산의 이중결합위치는 9번과 11번, 10번과 12번 및 11번과 13번이고 이중결합형태도 cis-cis, cis-trans, trans-cis, trans-trans 등이 있어, 총 12개의 공액리놀레산 이성질체의 존재가 알려져 있다. On the other hand, conjugated linoleic acid (CLA) is an isomer of linoleic acid and has a conjugated double bond structure. Linoleic acid has a cis-shaped double bond at 9 and 12 carbons, whereas the double bond position of conjugated linoleic acid is 9 and 11, 10 and 12 and 11 and 13, and the double bond type has cis-cis , cis-trans, trans-cis, trans-trans and the like, and a total of twelve conjugated linoleic acid isomers are known.
공액리놀레산(CLA)은 화학적으로 합성하거나 미생물에 의해 생산된다. 화학적으로 합성할 경우에는 공액리놀레산(CLA)의 이성질체가 모두 생산될 가능성이 있지만, 미생물에 의해서는 cis-9, trans-11 공액리놀레산(CLA)가 주로 생산된다. 반추위 동물에서 유래한 육류에는 공액리놀레산(CLA)이 아주 낮은 농도로 함유되어 있고, 유산균 발효식품, 특히 요구르트는 탈지유를 사용하기 때문에 공액리놀레산(CLA)은 극미량으로 존재한다. The conjugated linoleic acid (CLA) is chemically synthesized or produced by microorganisms. When chemically synthesized, it is possible that all of the isomers of conjugated linoleic acid (CLA) are produced, but cis-9 and trans-11 conjugated linoleic acid (CLA) are mainly produced by microorganisms. Conjugated linoleic acid (CLA) is present in trace amounts because meat derived from rumen contains very low concentrations of conjugated linoleic acid (CLA), and lactic acid fermented foods, especially yogurt, use skimmed milk.
또한, 두유 등의 콩 관련 식품에는 공액리놀레산(CLA)이 존재하지 않는다. 일부 식용버섯 균사체 이용 탈지대두 액상발효를 통한 공액리놀레산(CLA) 생산에 대해 보고되어 있으며, 진균류(곰팡이류) 이용 두유 발효에 의한 공액리놀레산 생산이 보고되어 있을 뿐 식용버섯 균사체 혹은 진균류를 이용한 고체발효법에 의한 공액리놀레산(CLA) 생산에 대한 연구는 미미한 실정이다. In addition, there is no conjugated linoleic acid (CLA) in soy-related foods such as soy milk. The production of conjugated linoleic acid (CLA) through liquid fermentation of defatted soybean using some edible mushroom mycelium has been reported and the production of conjugated linoleic acid by soybean fermentation using fungi (fungi) has been reported, and the solid fermentation method using edible mushroom mycelium or fungus The production of conjugated linoleic acid (CLA) by a microorganism is insignificant.
콩에는 영양성분 외에도 식물성 에스트로겐으로 알려진 이소플라본이 함유되어 있으며 이는 각종 성인병 예방에 효과가 있는 것으로 널리 알려져 있다. 이소플라본은 콩 품종에 따라 약간씩 차이를 보이지만 일반적으로 배당체인 glycosides가 25%, malonyl-glycosides가 70∼80%, acetyl-glycosides가 5% 그리고 비배당체인 aglycone이 2% 정도 존재하는 것으로 알려져 있다. 여러 그룹의 이소플라본들은 각각 생리활성을 나타내지만 특히 비배당체의 이소플라본이 체내 이용률이 높은 것으로 보고되어 있다. 이러한 콩은 콩 품종, 재배 환경, 발아, 가공 처리 및 미생물의 작용에 따라 이소플라본 함량이 달라질 수 있으며 일반적으로 배당체에서 비배당체 형태로의 전환은 증자, 열처리 혹은 발아와 발효 처리에 의해 일어나게 된다. 또한, 발효식품은 발효미생물이 생성하는 β-glycosidase 활성에 의해 당질이 분해되어 비배당체 형태로 전환된다. 그러나 대표적인 고체 발효법으로 발효되는 청국장은, 비배당체 생성율이 최대 40% 미만으로 좀 더 효율적인 고체 발효법이 필요하나, 고초균 같은 세균에서는 그 한계가 있고, 특유의 냄새로 기호도가 낮은 편이다.In addition to nutritional ingredients, soy contains isoflavones, known as vegetable estrogens, which are widely known to be effective in preventing various adult diseases. It is known that isoflavones vary slightly depending on the soybean varieties, but generally glycosides 25%, malonyl-glycosides 70-80%, acetyl-glycosides 5% and aglycone 2% . Although several groups of isoflavones exhibit physiological activity, in particular, isoflavones of non-glycosides have been reported to have high bioavailability. These soybean varieties may vary in content of isoflavones depending on the soybean variety, cultivation environment, germination, processing, and action of microorganisms. In general, the conversion of glycosides to non-glycosyltransferases is caused by the increase, heat treatment or germination and fermentation treatment. In addition, fermented foods are degraded by β-glycosidase activity produced by fermenting microorganisms and converted to non-glycoside forms. However, the typical fermentation method using solid fermentation method requires a more efficient solid fermentation method with less than 40% of non-glycoside production rate. However, it is limited in bacteria such as Bacillus subtilis and has a low preference due to its unique smell.
본 발명의 배경기술로는 대한민국 공개특허공보 제10-2009-0081598호에 콩 분말 용액 발효물의 제조방법이 기재되어 있다.As a background of the present invention, Korean Patent Laid-Open No. 10-2009-0081598 describes a method for producing fermented soybean powder solution.
본 발명자들은 당해 기술분야에서 지속적인 연구를 한 결과, 까치버섯 등 버섯을 이용한 콩 고체 발효를 통하여 제조된 콩발효물은 공액리놀레산(CLA) 및 비배당체 이소플라본 함량이 증대되고 항산화 활성, 당뇨 및 비만 개선효과와 같은 기능성이 증진되고 또한 청국장에 비하여 암모니아와 같은 발효취가 감소되는 것을 발견하고 본 발명을 완성하였다. As a result of continuous research in the related art, the inventors of the present invention have found that soybean fermented product produced by soybean solid fermentation using mushroom such as shrike mushroom has an increased content of conjugated linoleic acid (CLA) and non-glycosylated isoflavone and antioxidant activity, And the fermentation odor such as ammonia is reduced as compared with that of Chungkukjang. Thus, the present invention has been completed.
따라서, 본 발명의 목적은 공액리놀레산 및 비배당체 이소플라본 함량이 증대된, 버섯에 의해 고체 발효된 콩발효물을 제공하는 것이다.Accordingly, an object of the present invention is to provide a fermented soybean which is solid fermented by mushroom, wherein the content of conjugated linoleic acid and non-glycoside isoflavone is increased.
본 발명의 다른 목적은 암모니아 함량이 감소하고 풍미가 개선되고, 항산화 활성, 당뇨 및 비만 개선효과와 같은 기능성이 증진된 고품질의 콩발효물을 제공하는 것이다.Another object of the present invention is to provide a high-quality soybean fermentation product having reduced ammonia content, improved flavor, and improved functionality such as antioxidant activity, diabetes and obesity improving effect.
본 발명의 또 다른 목적은 상기 콩발효물을 포함하는 식품을 제공하는 것이다.It is still another object of the present invention to provide a food comprising the soybean fermented product.
본 발명의 또 다른 목적은 비배당체 생성율을 높일 수 있는 콩의 고체 발효 방법을 제공하는 것이다. It is another object of the present invention to provide a solid fermentation method of soybeans capable of increasing the non-glycoside production rate.
본 발명의 또 다른 목적은 상기 고품질의 콩발효물을 경제적이고 효율적으로 제조할 수 있는 콩 발효물의 제조 방법을 제공하는 것이다.It is still another object of the present invention to provide a method for producing a soybean fermented product capable of economically and efficiently producing the high-quality soybean fermented product.
본 발명의 목적은 이상에서 언급한 목적들로 제한되지 않으며, 언급되지 않은 또 다른 목적들은 상세한 설명의 기재로부터 명확하게 이해될 수 있을 것이다.The object of the present invention is not limited to the above-mentioned objects, and other objects not mentioned can be clearly understood from the description of the detailed description.
본 발명의 일 측면에 따르면, 본 발명은 까치버섯, 송이버섯, 및 잎새버섯에서 선택되는 1종 이상의 버섯 균사체 및 그 배양물 중 적어도 하나 이상; 및 증자시킨 콩을 포함하는, 버섯에 의해 고체 발효된 콩발효물이 제공된다.According to one aspect of the present invention, there is provided a method for producing a mushroom mycelium comprising at least one or more of at least one mushroom mycelium selected from magpie mushroom, pine mushroom, and mushroom and a culture thereof; And fermented soybean fermented solid by mushroom, including soybeans added.
본 발명의 일 실시예에 따르면, 본 발명의 콩발효물은 공액리놀레산 및 비배당체 이소플라본 함량 중 적어도 하나 이상이 증대될 수 있다. According to one embodiment of the present invention, the soybean fermentation product of the present invention can increase at least one of the contents of the conjugated linoleic acid and the non-glycoside isoflavone.
본 발명의 일 실시예에 따르면, 본 발명의 콩발효물은 암모니아 함량이 감소하고 풍미가 개선될 수 있다.According to one embodiment of the present invention, the fermented soybean of the present invention can reduce the ammonia content and improve the flavor.
본 발명의 일 실시예에 따르면, 상기 콩은 수침콩 또는 발아콩일 수 있다. According to one embodiment of the present invention, the beans may be soaked beans or germinated beans.
본 발명의 다른 측면에 따르면, 상기 콩발효물을 포함하는 식품이 제공된다.According to another aspect of the present invention, there is provided a food comprising the soybean fermented product.
본 발명의 일 실시예에 따르면, 상기 식품은 분말, 과립, 편상(flake), 페이스트, 시럽, 겔, 젤리, 바(bar), 환(pill), 정제(tablet), 캡슐, 및 액상 중에서 선택되는 형태로 가공될 수 있다.According to one embodiment of the present invention, the food is selected from a powder, a granule, a flake, a paste, a syrup, a gel, a jelly, a bar, a pill, a tablet, Or the like.
본 발명의 일 실시예에 따르면, 상기 식품은 항산화 활성, 당뇨 또는 비만의 예방 또는 개선 효과가 있는 기능성 식품일 수 있다.According to one embodiment of the present invention, the food may be a functional food having antioxidative activity, diabetes or obesity prevention or improvement effect.
본 발명의 또 다른 측면에 따르면, 까치버섯, 송이버섯, 및 잎새버섯에서 선택되는 1종 이상의 버섯 균사체 및 그 배양물 중 적어도 하나 이상을 증자시킨 콩에 접종하는 접종단계; 및 상기 콩을 발효시키는 발효단계를 포함하는 콩의 고체 발효 방법이 제공된다.According to still another aspect of the present invention, there is provided a method for producing soybean mushroom, comprising the steps of: inoculating a soybean which has been cultivated with at least one of mushroom mycelia selected from magpie mushroom, mushroom mushroom, and mushroom and a culture thereof; And a fermentation step of fermenting the soybeans.
본 발명의 또 다른 측면에 따르면, 까치버섯, 송이버섯, 및 잎새버섯에서 선택되는 1종 이상의 버섯 균사체 및 그 배양물 중 적어도 하나 이상을 증자시킨 콩에 접종하는 접종단계; 및 상기 콩을 발효시키는 발효단계를 포함하는 콩발효물의 제조 방법이 제공된다.According to still another aspect of the present invention, there is provided a method for producing soybean mushroom, comprising the steps of: inoculating a soybean which has been cultivated with at least one of mushroom mycelia selected from magpie mushroom, mushroom mushroom, and mushroom and a culture thereof; And a fermentation step of fermenting the soybean.
본 발명의 일 실시예에 따르면, 상기 접종단계에서 콩을 증자하기 전에 수침하거나 발아시키는 단계를 더 포함할 수 있다.According to an embodiment of the present invention, the seeding step may further include soaking or germinating the soybeans before the soybean is grown.
본 발명의 일 실시예에 따르면, 상기 접종단계에서 버섯 균사체 또는 그 배양물은 콩 중량에 대해 5~10 중량부로 접종할 수 있다.According to one embodiment of the present invention, in the step of inoculation, the mushroom mycelium or the culture thereof may be inoculated at 5 to 10 parts by weight with respect to the weight of the soybean.
본 발명의 일 실시예에 따르면, 상기 접종단계 이전에 버섯을 상온에서 4~6일간 배양하는 단계를 더 포함할 수 있다. According to an embodiment of the present invention, the mushroom may be cultured at room temperature for 4 to 6 days before the inoculation step.
본 발명의 일 실시예에 따르면, 상기 발효단계는 20~30℃에서 5~ 10일간 발효시킬 수 있다.According to an embodiment of the present invention, the fermentation step may be performed at 20 to 30 ° C for 5 to 10 days.
본 발명의 일 실시예에 따르면, 상기 발효단계 후 건조 후 분말화 시키는 단계를 더 포함할 수 있다.According to an embodiment of the present invention, the method may further include a step of drying and pulverizing after the fermentation step.
본 발명의 일 실시예에 따르면, 상기 분말화 시키는 단계는 발효된 콩을 45~55℃에서 2~3일간 건조할 수 있다. According to an embodiment of the present invention, the pulverizing step may be performed by drying the fermented soybeans at 45 to 55 ° C for 2 to 3 days.
본 발명의 일 실시예에 따르면, 상기 발효단계 후 콩발효물을 분말, 과립, 편상(flake), 페이스트, 시럽, 겔, 젤리, 바(bar), 환(pill), 정제(tablet), 캡슐, 및 액상으로 제형화하는 단계를 더 포함할 수 있다. According to an embodiment of the present invention, after the fermentation step, the fermented soybean may be used as a powder, a granule, a flake, a paste, a syrup, a gel, a jelly, a bar, a pill, , And < RTI ID = 0.0 > formulating < / RTI >
본 발명의 일 실시예에 따른 콩발효물은 공액리놀레산 및 비배당체 이소플라본 함량이 증대될 수 있다. The soybean fermented product according to an embodiment of the present invention can increase the content of the conjugated linoleic acid and the non-glycoside isoflavone.
본 발명의 일 실시예에 따른 콩발효물은 발효취 및 암모니아 함량이 감소하고 풍미가 개선되어, 선식 타입의 분말제, 과립제, 환제, 타블렛제 및 음료 등 다양한 형태의 식품으로 가공될 수 있다.The soybean fermented product according to an embodiment of the present invention may be processed into various types of foods such as an alginate type powder, granule, pills, tablet, and beverage, because the fermented soybean and ammonia contents are reduced and the flavor is improved.
본 발명의 일 실시예에 따른 콩발효물을 이용하면 항산화 활성, 당뇨 및 비만 개선 효과와 같은 기능성이 증진된 기능성 식품을 제공할 수 있다. The soybean fermented product according to one embodiment of the present invention can provide a functional food having improved functionality such as antioxidant activity, diabetes and obesity improving effect.
본 발명의 일 실시예에 따른 콩의 고체 발효 방법은 비배당체 생성율을 40% 이상으로 높일 수 있다. The solid fermentation method of soybean according to one embodiment of the present invention can increase the non-glycoside production rate to 40% or more.
본 발명의 일 실시예에 따른 콩발효물의 제조방법은 공액리놀레산 및 비배당체 이소플라본 함량이 증대된 고품질의 콩발효물을 경제적이고 효율적으로 제조할 수 있다.The method of manufacturing a soybean fermented product according to an embodiment of the present invention can economically and efficiently produce a high quality soybean fermented product in which the content of conjugated linoleic acid and nonisaccharide isoflavone is increased.
도 1은 본 발명의 일 실시예에 따라 제조된 식용버섯 균사체 콩발효물 사진이다. 도 1의 A는 발효 전 콩 사진이며, B는 송이버섯 균사체 콩발효물 사진이며, C는 잎새버섯 균사체 콩발효물 사진이며, D는 까치버섯 균사체 콩발효물 사진이다.
도 2는 본 발명의 일 실시예에 따라 제조된 콩발효물들의 공액리놀렌산 GC 크로마토그램이다. 도 2의 A는 발효 전 콩의 GC 크로마토그램을 나타낸 것이며, B는 송이버섯 균사체 콩발효물의 GC 크로마토그램을 나타낸 것이며, C는 잎새버섯 균사체 콩발효물의 GC 크로마토그램을 나타낸 것이며, D는 까치버섯 균사체 콩발효물의 GC 크로마토그램을 나타낸 것이다.
도 3은 본 발명의 일 실시예에 따른 수침콩과 발아콩을 나타낸 사진이다. 도 3의 A는 수침콩을 나타낸 것이며, B는 발아콩을 나타낸 것이다.
도 4는 종래 기술에 의한 청국장 분말 및 본 발명의 일 실시예에 따른 식용버섯 균사체 콩발효물 분말의 사진이다. 도 4의 A는 청국장 분말을 나타낸 것이며, B는 까치버섯 균사체에 의한 수침콩 발효물 분말을 나타낸 것이며, C는 까치버섯 균사체에 의한 발아콩 발효물 분말을 나타낸 것이다.
도 5는 본 발명의 일 실시예에 따라 제조된 콩발효물들의 이소플라본 HPLC 크로마토그램이다. 도 5의 A는 청국장 분말의 이소플라본 HPLC 크로마토그램을 나타낸 것이며, B는 까치버섯 균사체에 의한 수침콩 발효물 분말의 이소플라본 HPLC 크로마토그램을 나타낸 것이며, C는 까치버섯 균사체에 의한 발아콩 발효물 분말의 이소플라본 HPLC 크로마토그램을 나타낸 것이다.
도 6은 본 발명의 일 실시예에 따라 제조된 콩발효물들의 유리아미노산 및 암모니아 아미노산 자동분석기 크로마토그램이다. 도 6의 A는 청국장 분말의 유리아미노산 및 암모니아 아미노산 자동분석기 크로마토그램을 나타낸 것이며, B는 까치버섯 균사체에 의한 수침콩 발효물 분말의 유리아미노산 및 암모니아 아미노산 자동분석기 크로마토그램을 나타낸 것이며, C는 까치버섯 균사체에 의한 발아콩 발효물 분말의 유리아미노산 및 암모니아 아미노산 자동분석기 크로마토그램을 나타낸 것이다.FIG. 1 is a photograph of soybean fermented product of an edible mushroom mycelium produced according to an embodiment of the present invention. Fig. 1 (A) is a photograph of soybeans before fermentation, B is photograph of soybean fermented product of mycelium of mushroom mycelium, C is photograph of soybean fermentation product of mycelia of leaf mushroom, and D is photograph of soybean fermentation product of black mushroom mycelium.
FIG. 2 is a GC chromatogram of conjugated linolenic acid of soybean fermentations prepared according to one embodiment of the present invention. 2 shows GC chromatogram of soybeans before fermentation, B shows GC chromatogram of soybean fermented mycelia, C shows GC chromatogram of fermented soybean mycelia, and D shows black pepper mushroom GC chromatogram of fermented soybean mycelium.
FIG. 3 is a photograph showing soaked beans and sprouted beans according to an embodiment of the present invention. Fig. 3 (A) shows soaked soybeans, and B shows germinated soybeans.
4 is a photograph of a fermented soybean powder according to the prior art and a bean fermented product powder of mycelia of edible mushrooms according to an embodiment of the present invention. FIG. 4A shows chungkukjang powder, B shows the powder of soaked soybean fermented by the magpie mushroom, and C shows the fermented powder of germinated soybean by the magpie mushroom mycelium.
5 is isoflavone HPLC chromatogram of soybean fermentations prepared according to one embodiment of the present invention. FIG. 5A shows the isoflavone HPLC chromatogram of the chrysanthemum powder, B shows the isoflavone HPLC chromatogram of the soaked fermented soybean powder with the mycelium of magpie, and C shows the fermented soybean fermented product Isoflavone HPLC chromatogram of the powder.
FIG. 6 is a chromatogram of free amino acid and ammonia amino acid automatic analyzer of soybean fermentations prepared according to an embodiment of the present invention. FIG. 6A shows the chromatogram of the free amino acid and ammonia amino acid analyzer of the chungkukjang powder, B shows the chromatogram of free amino acid and ammonia amino acid automatic analyzer of the soaking fermented soybean powder with the mycelium of magpie mushroom, The chromatogram of free amino acid and ammonia amino acid analyzer of germinated fermented soybean powder by mushroom mycelium is shown.
본 출원에서 사용한 용어는 단지 특정한 실시 예를 설명하기 위해 사용된 것으로, 본 발명을 한정하려는 의도가 아니다. 단수의 표현은 문맥상 명백하게 다르게 뜻하지 않는 한, 복수의 표현을 포함한다.The terminology used in this application is used only to describe a specific embodiment and is not intended to limit the invention. The singular expressions include plural expressions unless the context clearly dictates otherwise.
본 출원에서, '포함하다' 또는 '가지다' 등의 용어는 명세서상에 기재된 특징, 숫자, 단계, 동작, 구성요소, 부품 또는 이들을 조합한 것이 존재함을 지정하려는 것이지, 하나 또는 그 이상의 다른 특징들이나 숫자, 단계, 동작, 구성요소, 부품 또는 이들을 조합한 것들의 존재 또는 부가 가능성을 미리 배제하지 않는 것으로 이해되어야 한다.In this application, the terms "comprises", "having", and the like are intended to specify the presence of stated features, integers, steps, operations, components, parts, or combinations thereof, But do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components, or combinations thereof.
본 출원에서, 어떤 부분이 어떤 구성요소를 "포함"한다고 할 때, 이는 특별히 반대되는 기재가 없는 한 다른 구성요소를 제외하는 것이 아니라 다른 구성요소를 더 포함할 수 있는 것을 의미한다. In the present application, when a component is referred to as " comprising ", it means that it can include other components as well, without excluding other components unless specifically stated otherwise.
본 발명은 다양한 변환을 가할 수 있고 여러 가지 실시 예들을 가질 수 있는 바, 특정 실시 예들을 도면에 예시하고 상세한 설명에 상세하게 설명하고자 한다. 그러나, 이는 본 발명을 특정한 실시 형태에 대해 한정하려는 것이 아니며, 본 발명의 사상 및 기술 범위에 포함되는 모든 변환, 균등물 내지 대체물을 포함하는 것으로 이해되어야 한다. 본 발명을 설명함에 있어서 관련된 공지 기술에 대한 구체적인 설명이 본 발명의 요지를 흐릴 수 있다고 판단되는 경우 그 상세한 설명은 생략한다.BRIEF DESCRIPTION OF THE DRAWINGS The present invention is capable of various modifications and various embodiments, and particular embodiments are illustrated in the drawings and will be described in detail in the detailed description. It is to be understood, however, that the invention is not to be limited to the specific embodiments, but includes all modifications, equivalents, and alternatives falling within the spirit and scope of the invention. In the following description, well-known functions or constructions are not described in detail since they would obscure the invention in unnecessary detail.
본 발명의 일 측면에 따르면, 본 발명은 까치버섯, 송이버섯, 및 잎새버섯에서 선택되는 1종 이상의 버섯 균사체 및 그 배양물 중 적어도 하나 이상; 및 증자시킨 콩을 포함하는, 버섯에 의해 고체 발효된 콩발효물이 제공된다.According to one aspect of the present invention, there is provided a method for producing a mushroom mycelium comprising at least one or more of at least one mushroom mycelium selected from magpie mushroom, pine mushroom, and mushroom and a culture thereof; And fermented soybean fermented solid by mushroom, including soybeans added.
본 발명의 콩발효물은 공액리놀레산 및 비배당체 이소플라본 함량 중 적어도 하나 이상이 증대될 수 있다. 특히 비배당체 이소플라본의 함량을 40% 이상으로 높일 수 있다.The soybean fermented product of the present invention can increase at least one of the contents of the conjugated linoleic acid and the non-glycoside isoflavone. In particular, the content of the non-glycoside isoflavone can be increased to 40% or more.
상기 까치버섯(Polyozellus multiplex)은 높이 5∼15 cm 너비 5∼30 cm 정도로 강원도 일대에서 소나무와 같은 침엽수림 그리고 활엽수림에 군생하는 식용버섯으로 알려져 있다. 강원도 일부 지역에서는 “먹버섯”, 양양 지역에서는 “고무버섯”또는 “곰버섯”이라고도 알려져 있다. 까치버섯은 위암예방, 항암효능과 치매를 예방하는 효능이 있는 것으로 알려져 있다. 본 발명에 의하면 상기 까치버섯의 균사체 또는 그 배양물은 콩의 고체 발효에 이용시 공액리놀레산 및/또는 비배당체 이소플라본 함량을 증대시킬 수 있다. 상기 까치버섯은 상대적으로 다른 버섯에 비해 공액리놀레산 생성력이 우수하다.The Polyozellus multiplex is 5 to 15 cm in width and 5 to 30 cm in height. It is known as an edible mushroom that grows in coniferous forests such as pine trees and broad-leaved forests in Gangwon Province. In some parts of Gangwon-do, it is known as "mushroom", and in Yangyang area it is also known as "rubber mushroom" or "bear mushroom". It is known that magpie mushroom has the effect of preventing stomach cancer, anticancer efficacy and preventing dementia. According to the present invention, the mycelia or culture thereof of the black mushroom can increase the content of conjugated linoleic acid and / or non-glycoside isoflavone when used for solid fermentation of soybean. The magpie mushroom is superior to other mushrooms in producing conjugated linoleic acid.
상기 송이버섯(Tricholoma matsutake)은 적송(赤松)의 잔뿌리에서 자라는 버섯으로 적송의 잔뿌리에 균근(菌根)을 형성하여 공생한다. 해마다 가을이면(19℃ 정도) 균사의 군데군데가 팽대하여 싹이 생기고, 이것이 갑자기 발육하여 약 2주일이면 지상에 나타나기 시작하여 자실체를 형성한다. 송이버섯은 살이 두껍고 향기로우며 맛좋은 야생 버섯으로 식용 및 항암 등 약용 가치가 있는 것으로 알려져 있다. 본 발명에 의하면 상기 송이버섯의 균사체 또는 그 배양물은 콩의 고체 발효에 이용시 공액리놀레산 및/또는 비배당체 이소플라본 함량을 증대시킬 수 있다.The above mushroom ( Tricholoma matsutake ) is a mushroom that grows in the roots of red pines and forms mycorrhiza in the roots of red pines. Every year in the autumn (about 19 ℃), mycelium grows and grows suddenly. It grows suddenly and starts appearing on the ground about two weeks later, forming fruiting body. Pine mushroom is thick, fragrant, and delicious wild mushroom. It is known to have medicinal value such as edible and anti-cancer. According to the present invention, the mycelium of pine mushroom or the culture thereof can increase the content of conjugated linoleic acid and / or non-glycoside isoflavone when used for solid fermentation of soybean.
상기 잎새버섯(Grifola frondosa)은 은행나뭇잎처럼 생긴 갓들이 여러 겹 겹쳐져 자실체 다발을 이루고 색은 흑색, 흑갈색, 회갈색, 백색이다. 잎새버섯은 맛도 좋으면서 약리 작용이 뛰어나 항암효과와 종양저지율이 높은 것으로 알려져 있다. 본 발명에 의하면 상기 잎새버섯의 균사체 또는 그 배양물은 콩의 고체 발효에 이용시 공액리놀레산 및/또는 비배당체 이소플라본 함량을 증대시킬 수 있다.The leaf mushroom ( Grifola frondosa ) is a group of leaf-like glands that are folded in layers to form a bundle of fruit bodies. The colors are black, dark brown, grayish brown, and white. Leaf mushrooms are known to have good anticancer effects and tumor suppression rates because they have good taste and good pharmacological action. According to the present invention, the mycelium of the mushroom or the culture thereof can increase the content of conjugated linoleic acid and / or non-glycoside isoflavone when used for solid fermentation of soybean.
본 발명에 있어, 콩은 종류를 불문하고 콩으로 분류되는 식물로부터 얻어진 모든 열매를 포함하는 의미이다. 이에 한정되는 것은 아니나, 완두콩, 강낭콩, 서목태, 청태, 동부, 밤콩, 백태(노란콩), 나물콩, 밥밑콩, 작두콩, 서리태, 풋콩 등을 예로 들 수 있다.In the present invention, beans are meant to include all the fruits obtained from plants classified as beans, regardless of their kind. Examples include, but are not limited to, peas, beans, seomyeotae, chungtae, eastern, bamboo, white beans, herb beans, rice bran, soybean, seaweed and soybean.
본 발명에 있어, 콩발효물은 콩을 원료로 하는 미생물의 발효 작용을 이용하여 제조한 것을 의미한다. In the present invention, the soybean fermented product means that fermented soybean is produced by using the fermentation action of a microorganism using soybean as a raw material.
본 발명의 일 실시예에 따르면, 본 발명의 콩발효물은 암모니아 함량이 감소하고 풍미가 개선될 수 있다. 본 발명에 의해 제조된 콩발효물은 고초균에 의한 고체발효법에 의해 발효되는 청국장과 비교해서 암모니아 함량이 감소하고 풍미가 개선되어 기호도가 높아진다.According to one embodiment of the present invention, the fermented soybean of the present invention can reduce the ammonia content and improve the flavor. The soybean fermented product produced by the present invention has reduced ammonia content and improved flavor as compared with chungkukjang fermented by solid fermentation method using Bacillus subtilis.
본 발명의 일 실시예에 따르면, 이에 한정되는 것은 아니나 상기 콩은 수침콩 또는 발아콩일 수 있다. 상기 수침콩 또는 발아콩을 이용 시 공액리놀레산 및/또는 비배당체 이소플라본 함량을 증대시킬 수 있다.According to one embodiment of the present invention, the beans may be soaked beans or germinated beans, although not limited thereto. When the soya bean or sprouts are used, the content of conjugated linoleic acid and / or non-glycoside isoflavone can be increased.
본 발명의 다른 측면에 따르면, 상기 콩발효물을 포함하는 식품이 제공된다.According to another aspect of the present invention, there is provided a food comprising the soybean fermented product.
상술한 바와 같이, 본 발명에 의해 제조된 콩발효물은 공액리놀레산 및 비배당체 이소플라본 함량 중 적어도 하나가 증대되고, 암모니아 함량이 감소하고 풍미가 개선되어 식품으로 이용될 수 있고, 면, 빵, 과자, 음료 등의 식품 첨가제로서도 이용될 수도 있다.As described above, the soybean fermented product produced by the present invention can be used as a food by increasing at least one of the contents of the conjugated linoleic acid and the non-glycoside isoflavone, reducing the ammonia content and improving the flavor, It can also be used as a food additive such as confectionery and beverage.
본 발명의 일 실시예에 따르면, 이에 한정되는 것은 상기 식품은 분말, 과립, 편상(flake), 페이스트, 시럽, 겔, 젤리, 바(bar), 환(pill), 정제(tablet), 캡슐, 및 액상 중에서 선택되는 형태로 가공될 수 있다.According to an embodiment of the present invention, the food is limited to a powder, a granule, a flake, a paste, a syrup, a gel, a jelly, a bar, a pill, a tablet, And a liquid phase.
본 발명의 일 실시예에 따르면, 상기 식품은 항산화 활성, 당뇨 또는 비만의 예방 또는 개선 효과가 있는 기능성 식품일 수 있다. 본 발명에 의한 콩발효물은 공액리놀레산 및 비배당체 이소플라본 함량 중 적어도 하나가 증대되어 이를 식품 또는 식품첨가제로 이용시 항산화 활성, 당뇨 또는 비만의 예방 또는 개선 효과의 기능성 식품으로 활용될 수 있다. According to one embodiment of the present invention, the food may be a functional food having antioxidative activity, diabetes or obesity prevention or improvement effect. The soybean fermented product according to the present invention can be utilized as a functional food for preventing or improving antioxidant activity, diabetes or obesity when at least one of the contents of at least one of conjugated linoleic acid and non-glycoside isoflavone is increased as a food or food additive.
본 발명에 있어, 상기 항산화 활성은 활성산소종(singlet oxygen, superoxide anion, superoxiradical, hydrogen peroxide)을 소거시키거나 그 증가를 억제하거나 그 유해성을 억제하는 활성을 의미한다. 본 발명의 하기 실시예에서는 DPPH 라디칼의 소거 활성을 통하여 이를 검증하였다.In the present invention, the antioxidant activity means an activity of eliminating, suppressing or suppressing the harmfulness of singlet oxygen, superoxide anion, superoxiradical or hydrogen peroxide. In the following examples of the present invention, the DPPH radical scavenging activity was verified.
본 발명에 의한 콩발효물은 이에 한정되는 것은 아니나 분말화하여 면, 빵 또는 과자의 원료 혼합물의 제조시에 첨가하고 반죽하여 일정 형태로 성형하여 익혀서 면, 빵, 또는 과자를 제조할 수 있다. 상기 면, 빵 또는 과자 제조 시 당업계에서 통상 사용되는 성분들의 혼합물을 이용할 수 있다. 상기 면, 빵 또는 과자의 제조에 있어, 콩발효물의 첨가량은 최고 99.99%까지도 가능하다. The soybean fermented product according to the present invention is not limited to the soybean fermented product but may be powdered and added to the raw material mixture of cotton, bread or pastry, kneaded, and shaped into a predetermined shape to prepare cotton, bread or confection. Mixtures of ingredients commonly used in the art can be used to make such surfaces, breads or confections. In the production of the surface, bread, or confection, the amount of soybean fermentation product added can be up to 99.99%.
본 발명의 또 다른 측면에 따르면, 까치버섯, 송이버섯, 및 잎새버섯에서 선택되는 1종 이상의 버섯 균사체 및 그 배양물 중 적어도 하나 이상을 증자시킨 콩에 접종하는 접종단계; 및 상기 콩을 발효시키는 발효단계를 포함하는 콩의 고체 발효 방법이 제공된다.According to still another aspect of the present invention, there is provided a method for producing soybean mushroom, comprising the steps of: inoculating a soybean which has been cultivated with at least one of mushroom mycelia selected from magpie mushroom, mushroom mushroom, and mushroom and a culture thereof; And a fermentation step of fermenting the soybeans.
본 발명의 콩의 고체 발효 방법에 의하면, 콩발효물의 공액리놀레산 및 비배당체 이소플라본 함량 중 적어도 하나 이상이 증대될 수 있다. 특히 비배당체 이소플라본의 함량을 40% 이상으로 높일 수 있다. 또한, 본 발명의 콩의 고체 발효 방법에 의하면, 콩발효물은 고초균에 의한 고체발효법에 의해 발효되는 청국장과 비교해서 암모니아 함량이 감소하고 풍미가 개선되어 기호도가 높아진다.According to the solid fermentation method of soybean of the present invention, at least one of the contents of the conjugated linoleic acid and the non-glycoside isoflavone of the fermented soybean can be increased. In particular, the content of the non-glycoside isoflavone can be increased to 40% or more. Further, according to the solid fermentation method of soybean of the present invention, the soybean fermented product has a reduced ammonia content and an improved flavor as compared with chungkukjang fermented by solid fermentation method with Bacillus subtilis.
본 발명의 또 다른 측면에 따르면, 까치버섯, 송이버섯, 및 잎새버섯에서 선택되는 1종 이상의 버섯 균사체 및 그 배양물 중 적어도 하나 이상을 증자시킨 콩에 접종하는 접종단계; 및 상기 콩을 발효시키는 발효단계를 포함하는 콩발효물의 제조 방법이 제공된다.According to still another aspect of the present invention, there is provided a method for producing soybean mushroom, comprising the steps of: inoculating a soybean which has been cultivated with at least one of mushroom mycelia selected from magpie mushroom, mushroom mushroom, and mushroom and a culture thereof; And a fermentation step of fermenting the soybean.
본 발명의 콩발효물의 제조 방법에 의하면, 콩발효물의 공액리놀레산 및 비배당체 이소플라본 함량 중 적어도 하나 이상이 증대될 수 있다. 특히 비배당체 이소플라본의 함량을 40% 이상으로 높일 수 있다. 또한, 본 발명의 콩발효물 제조 방법에 의하면, 콩발효물은 고초균에 의한 고체발효법에 의해 발효되는 청국장과 비교해서 암모니아 함량이 감소하고 풍미가 개선되어 기호도가 높아진다.According to the method for producing a soybean fermented product of the present invention, at least one of the contents of the conjugated linoleic acid and the unglycosylated isoflavone of the soybean fermented product can be increased. In particular, the content of the non-glycoside isoflavone can be increased to 40% or more. Further, according to the method for producing soybean fermented product of the present invention, the soybean fermented product has reduced ammonia content and improved flavor as compared with chungkukjang, which is fermented by solid fermentation method using Bacillus subtilis.
본 발명에 있어서, 상기 증자는 살균 및 발효를 유도하기 콩을 삶는 것으로 영양성분이 파괴되지 않는 한 살균되도록 삶는다면 특별한 한정은 없다. 예를 들어 120℃에서 30 ~ 60분간 증자할 수 있다. 이때 살균 시간이 30분 이하인 경우 콩이 덜 삶아지거나 살균되지 않아 발효가 진행되지 않을 수 있으며, 60분 이상인 경우 과도한 살균 및 영양성분 등의 소실이 다수 일어날 수 있다. In the present invention, there is no particular limitation as long as the soy sauce is boiled so as to induce sterilization and fermentation and sterilized unless the nutritional ingredients are destroyed. For example, at 120 ° C for 30 to 60 minutes. If the sterilization time is less than 30 minutes, the soybean may not be boiled or sterilized and the fermentation may not proceed. If the sterilization time is more than 60 minutes, excessive disinfection and nutrients may be lost.
본 발명의 일 실시예에 따르면, 상기 접종단계에서 콩을 증자하기 전에 수침하거나 발아시키는 단계를 더 포함할 수 있다. 상기 수침은 콩에 충분한 수분을 제공한다면 수침의 조건에는 특별한 한정은 없다. 예를 들어 부피로 콩 3배의 물을 가하여 상온에서 8-12시간 동안 수침할 수 있다. 상기 발아는 콩의 싹이 발생 또는 생장을 개시하는 것으로, 발아 조건에는 특별한 한정은 없다. 예를 들어 상기 수침한 콩의 2배만큼 싹을 틔워 발아콩을 제조할 수 있다.According to an embodiment of the present invention, the seeding step may further include soaking or germinating the soybeans before the soybean is grown. There is no particular limitation on the condition of soaking if the soaking provides sufficient moisture to the soybean. For example, three times as much water as beans can be added to the flour and the flour can be soaked at room temperature for 8-12 hours. The germination initiates the generation or growth of the bud of the soybean, and the germination condition is not particularly limited. For example, germinated soybeans can be produced by sprouting two times as much of the soaked soybeans.
본 발명의 일 실시예에 따르면, 상기 접종단계에서 버섯 균사체 또는 그 배양물은 콩 중량에 대해 5~10 중량부로 접종할 수 있다. 버섯 균사체 또는 그 배양물이 콩 중량에 대해 5 중량부 미만이면 발효 속도가 지연되며, 10 중량부를 초과하면 발효 속도와 상관없이 경제성이 없다.According to one embodiment of the present invention, in the step of inoculation, the mushroom mycelium or the culture thereof may be inoculated at 5 to 10 parts by weight with respect to the weight of the soybean. If the mushroom mycelium or the cultured product thereof is less than 5 parts by weight based on the soybean weight, the fermentation rate is delayed, and if it exceeds 10 parts by weight, there is no economical efficiency irrespective of the fermentation rate.
본 발명의 일 실시예에 따르면, 상기 접종단계 이전에 버섯을 상온에서 5~15일간 배양하여 종균을 제공하는 단계를 더 포함할 수 있다. 버섯의 종균 배양은 당업계에서 알려진 공지의 기술을 이용하여 배양할 수 있다. 이에 한정되는 되는 것은 아니나, 예를 들어 백미를 수세하여 쌀 액체 배지를 제조하여 이 쌀 액체 배지를 이용하여 상온에서 5~15일간 배양할 수 있다.According to an embodiment of the present invention, the step of culturing the mushroom at room temperature for 5 to 15 days prior to the seeding step may further include providing seeds. The seed culture of the mushroom can be cultured using known techniques known in the art. For example, rice bran can be washed with water to prepare a liquid broth, and the broth can be cultured at room temperature for 5 to 15 days using the liquid broth.
본 발명의 일 실시예에 따르면, 상기 발효단계는 20~30℃에서 6~12일간 발효하는 것이 적합하나 이에 한정되는 것은 아니다. 발효온도가 20℃ 미만에서는 발효 속도가 지연되고, 30℃ 초과에서는 균사체 생육이 저해되어 발효 속도가 현저히 증가한다. 발효기간은 6일 미만이면 균사체 생육이 미흡하고, 8일 초과이면 유효성분 등이 감소할 수 있다. According to an embodiment of the present invention, the fermentation step is preferably performed at 20 to 30 ° C for 6 to 12 days, but is not limited thereto. When the fermentation temperature is lower than 20 캜, the fermentation rate is retarded. When the temperature is higher than 30 캜, the growth of the mycelium is inhibited and the fermentation rate is remarkably increased. If the fermentation period is less than 6 days, the mycelial growth is insufficient, and if it is more than 8 days, the active ingredient etc. may decrease.
본 발명의 일 실시예에 따르면, 상기 발효단계 후 건조 후 분말화 시키는 단계를 더 포함할 수 있다. 이에 한정되는 것은 아니나, 상기 건조는 45~55℃에서 2~3일 건조할 수 있다. 건조 온도가 45℃ 미만에서는 건조 기간이 길어지며, 고초균 등의 오염이 일어날 수 있고, 55℃ 초과에서는 상대적으로 영양성분이 파괴가 빠르게 진행될 수 있다. 또한, 필요에 따라 영양성분 파괴 등의 최소화를 위해 동결건조를 할 수 있다. 상기 건조된 콩은 분쇄기로 분쇄하여 분말로 제공될 수 있다. According to an embodiment of the present invention, the method may further include a step of drying and pulverizing after the fermentation step. The drying may be performed at 45 to 55 ° C. for 2 to 3 days. If the drying temperature is less than 45 ° C, the drying period becomes longer and contamination of Bacillus subtilis may occur. When the drying temperature exceeds 55 ° C, the nutrients may rapidly break down. If necessary, freeze-drying can be performed to minimize the destruction of nutritional ingredients. The dried beans may be pulverized by a pulverizer to be provided as a powder.
본 발명의 일 실시예에 따르면, 상기 발효단계 후 콩발효물을 분말, 과립, 편상(flake), 페이스트, 시럽, 겔, 젤리, 바(bar), 환(pill), 정제(tablet), 캡슐, 및 액상으로 제형화하는 단계를 더 포함할 수 있다. 상기 제형화 방법은 당업계의 공지된 기술을 이용하여 수행할 수 있다.According to an embodiment of the present invention, after the fermentation step, the fermented soybean may be used as a powder, a granule, a flake, a paste, a syrup, a gel, a jelly, a bar, a pill, , And < RTI ID = 0.0 > formulating < / RTI > The above-described formulation method can be carried out using a known technique in the art.
본 발명에 의한 버섯 균사체, 특히 까치버섯 균사체의 콩발효물은 공액리놀레산 함량이 생성능이 우수하다(시험예 1~2 및 실시예 1 참조), 또한, 본 발명에 의해 제조된 콩발효물은 통상의 고체 발효법으로 제조되는 청국장보다 공액리놀레산과 비배당체-이소플라본 함량이 높고, 또한 특유의 단백질 분해산물인 암모니아 함량이 낮아 발효취의 악취가 현저히 낮아 풍미가 개선되어 결과적으로 기호성이 현저히 증가한다(시험예 1 및 실시예 1~2 참조). 또한, 항산화 활성 및 당뇨 및 비만의 개선 효과가 현저히 증진되어 기능성 또한 탁월하다 (시험예 1 및 실시예 1~2 참조). The soybean fermented product of the mushroom mycelium according to the present invention, particularly the soybean fermented product of the magpie mushroom mycelium, is excellent in the production ability of the conjugated linoleic acid (see Test Examples 1 to 2 and Example 1) , The content of conjugated linoleic acid and non-glycoside-isoflavone is higher than that of cheonggukjang prepared by the solid fermentation method. Also, since the content of ammonia, which is a unique protein degradation product, is low, the odor of the fermentation odor is remarkably low and the flavor is improved. Test Example 1 and Examples 1 to 2). In addition, the antioxidative activity and the improvement effect of diabetes and obesity are remarkably improved, and the functionalities are also excellent (see Test Example 1 and Examples 1 to 2).
본 발명의 또 다른 목적에 따라서, 까치버섯 균사체 등을 이용하여 발효한 향미가 개선되어 풍미가 증진되고 항산화 활성, 당뇨 및 비만 개선효과와 같은 기능성이 증진된 고품질의 콩발효물 분말제, 과립제, 환제, 정제 및 음료를 제공할 수 있다. According to another object of the present invention, there is provided a high-quality soybean fermented milk powder, a granule, a granule, a flavor enhancer, an antioxidant activity improving effect, an improvement in diabetes and obesity, Pills, tablets and beverages.
다음의 실시예들에 의해 본 발명이 더 상세히 설명된다. 이들 실시예는 본 발명을 예시하기 위한 것이며, 본 발명의 범위가 이들에 의해 제한되어서는 안된다.The present invention will be described in more detail by the following examples. These examples are for illustrating the present invention, and the scope of the present invention should not be limited by them.
실시예Example 1 ~ 3: 식용버섯 균사체의 1 to 3: of edible mushroom mycelium 공액리놀레산Conjugated linoleic acid 생산능Production capacity 확인 Confirm
3종의 버섯 균사체(송이버섯, 잎새버섯 및 까치버섯)로부터 공액리놀레산(conjugated linoleic acid, CLA) 생성량을 확인하였다. The amount of conjugated linoleic acid (CLA) was determined from three mycelia of mushroom (pine mushroom, mushroom and mushroom).
시험예 1Test Example 1
i) 발효 종균 제조i) Production of fermented seeds
백미를 수세하여 12시간 수침 후 물기를 제거하고 250 mL 삼각플라스크에 10 g을 칭량하여 넣고 멸균수 90 mL를 첨가한 상태에서 121℃ 15분간 살균하여 10% 쌀 액체배지를 제조하였다. After washing with water for 12 hours, the water was removed, and 10 g was weighed into a 250 mL Erlenmeyer flask. Sterilized water (90 mL) was added and sterilized at 121 ° C for 15 minutes to prepare a 10% rice liquid medium.
여기에 송이버섯 균사체, 잎새버섯 균사체 및 까치버섯 균사체를 배양한 각각의 plate를 무균적으로 적당히 절단하여 10% 쌀 액체배지에 접종하여 25℃에서 10일간 배양하여 발효를 위한 종균을 준비하였다. Each of the plates cultivated with mycelium of matsutake mushroom, mushroom mycorrhiza mycelia and mushroom mycelia was inoculated aseptically into 10% rice liquid medium and cultured at 25 ° C for 10 days to prepare seeds for fermentation.
까치버섯 균사체는 경상남도 함양군 안의면 인근 야산에서 채취한 후 조직 분리하여 사용하였다. 까치버섯 균사체 배양은 2∼3달에 1회씩 potato dextrose (PDA, Difico, MI, USA) 고체 배지에 10일간 계대 이식하여 사용하였다.Mushroom mycorrhizae were collected from the nearby mountains of Anyeong - myeon, Hamyang - gun, Gyeongsangnam - do, The cultivation of mycorrhizal mushroom mycelium was carried out in a potato dextrose (PDA, Difico, MI, USA) solid medium for 10 days, once every 2-3 months.
ii) ii) 증자콩Increase soybean 제조 Produce
노란콩 3kg을 흐르는 물에 세척한 후 물기를 제거하고 20℃에서 12시간 수침한 후 물기를 제거하고 수침콩 200g을 폴리스티렌 발효용기에 각각 나누어 담은 후 121℃에서 30분간 증자하여 콩을 살균하였다. 3 kg of yellow soybeans were washed with flowing water, and water was removed. After water was dipped in 20 ° C for 12 hours, the water was removed. 200 g of soaked soybean was divided into polystyrene fermentation vessels, and the soybean was sterilized by heating at 121 ° C for 30 minutes.
iii) 발효iii) Fermentation
살균된 콩에 각각 준비된 종균 배양액을 각각 5%(w/v)로 접종한 후 25℃의 온도에서 12일간 발효시켰다(도 1). Each sterilized soybean was inoculated with 5% (w / v) each of the prepared seed culture and fermented at 25 ° C for 12 days (Fig. 1).
iv) iv) 콩발효물Soybean fermentation product 분말 제조 Powder manufacturing
상기 발효된 콩발효물을 50℃에서 3일간 건조하여 분쇄기로 분쇄하여 분말화 하였다. The fermented soybean fermented product was dried at 50 DEG C for 3 days, pulverized by a pulverizer, and pulverized.
<공액리놀렌산 분석>≪ Analysis of conjugated linolenic acid &
공액리놀레산 분석은 상기 제조된 분말 2g을 취하여 클로로포르(chloroform) : 메탄올(methanol)(1:1)을 가하여 지방산을 추출하고 지방산 분석 방법에 준하여 수행하였다. 즉, 지방산 분석은 식품공전법 지방산 분석법에 준하여 수행하였다. Analysis of the conjugated linoleic acid was carried out by extracting 2 g of the powder and extracting fatty acids by adding chloroform: methanol (1: 1) to the fatty acid analysis. That is, the fatty acid analysis was carried out according to the fatty acid analysis method of the food method.
지방산 분석 전 우선 콩 품종별 원료의 지방성분을 추출하였다. 즉, 각각의 품종별 콩 분말 10g에 클로로포름:메탄올(2:1) Folch 용액을 30mL를 가하고 상온에서 2시간 교반하여 지방을 추출하였다. Before the fatty acid analysis, the fat content of the raw materials of each soybean variety was extracted. That is, 30 mL of a chloroform: methanol (2: 1) Folch solution was added to 10 g of soybean powder for each breed, and the fat was extracted by stirring at room temperature for 2 hours.
지방 추출이 끝난 후 거름망에 걸러내고 이 여과액에 포화 NaCl 4mL를 첨가하여 층 분리가 일어나게 하였다. 층 분리가 일어난 지방층만을 다시 회수하여 무수아황산과 함께 탈수시켜 60℃에서 감압 농축하여 순수 지방을 회수하였다. After the extraction of fat, the filtrate was filtered and 4 mL of saturated NaCl was added to the filtrate. Only the fat layer with layer separation was recovered again, dehydrated with anhydrous sulfuric acid, and concentrated under reduced pressure at 60 ° C to recover pure fat.
얻어진 각각의 품종별 콩 지방 1mL에 0.5 N 메탄올성 NaOH 3mL를 가해 100℃ 10분간 가온하여 지방산과 글리세롤을 가수분해시켰다. 이후 삼불화붕소(BF3) 2mL를 가하여 교반한 후 30분간 다시 가온하여 지방산 메틸에스테르화를 진행하였다.To each 1 mL of soybean fat obtained, 3 mL of 0.5 N methanolic NaOH was added and heated at 100 ° C for 10 minutes to hydrolyze the fatty acid and glycerol. Then, 2 mL of boron trifluoride (BF 3 ) was added and stirred, and the mixture was heated again for 30 minutes to proceed with fatty acid methyl esterification.
반응이 끝난 후 이소옥탄 1mL를 첨가하고 격렬히 흔든 후 원심분리 하여 분리된 이소옥탄층만을 회수하여 무수황산나트륨과 함께 탈수한 뒤 0.45μm-membrane filter (Dismic-25CS)로 여과하여 GC를 이용하여 분석하였다.After the reaction was completed, 1 mL of isooctane was added, and the mixture was vigorously shaken, centrifuged, and the separated iso-octane layer was collected, dehydrated with anhydrous sodium sulfate, and filtered through a 0.45 μm-membrane filter (Dismic-25CS).
그 결과, 도 2에 나타난 바와 같이 발효 전 콩에서는 공액리놀렌산이 검출되지 않았고(비교예 1), 실시예 2와 3의 송이버섯 균사체와 잎새버섯 균사체 발효 후 콩에서는 약 총 공액리놀렌산 함량이 약 20~25μg/g로 생성되었고, 까치버섯 균사체 발효 후 콩(실시예 3)의 경우 약 2배 정도인 46μg/g 이상 생성이 되었다. 표 1은 식용버섯 균사체 콩발효물의 공액리놀레산(CLA) 조성 비교한 것을 나타낸다.As a result, as shown in Fig. 2, no conjugated linolenic acid was detected in the soybeans before fermentation (Comparative Example 1), and the total conjugated linolenic acid content of the soybean mushroom mycelium and the mushroom mycelia after fermentation of the mycelia of the mushrooms of Examples 2 and 3 was about 20 To 25 μg / g, and in the case of bean (Example 3) after the fermentation of the mushroom mycelium, about 46 μg / g was produced. Table 1 shows the composition of the conjugated linoleic acid (CLA) of soybean fermented product of the edible mushroom mycelium.
공액리놀렌산 함량
(μg/g)
Conjugated linolenic acid content
(μg / g)
발효 전 콩
(비교예 1)
Soybeans before fermentation
(Comparative Example 1)
발효 후 콩
Soybeans after fermentation
(송이버섯)Example 1
(Matsutake)
(잎새버섯)Example 2
(Leaf mushroom)
(까치버섯)Example 3
(Mushroom crab)
**nd; 검출되지 않음* All experiments were repeated three times
** nd; Not detected
실시예Example 4 및 5 : 4 and 5: 까치버섯 Shrike mushroom 균사체 이용 콩 고체발효를 통한 분말 제조 Production of powder through fermentation of bean solid using soybean
노란콩(품종명: 대원)을 12시간 수침한 후 25℃의 암실에서 수침콩의 약 2배 정도로 발아하여 발아콩을 제조하였고, 그 결과는 도 3과 같다. Yellow bean (product name: Daewon) was soaked for 12 hours and germinated at about 2 times of soaked soybeans in a dark room at 25 캜 to produce germinated soybean. The results are shown in Fig.
발아콩은 수침콩을 콩나물 재배기에 가지런히 놓고 빛을 차단한 상태에서 4시간 주기로 물을 공급해가며 낱알의 2배만큼 싹을 틔워 발아콩을 제조하였다.Sprouted beans were prepared by sprinkling two times as many grains while water was supplied to the bean sprouts in a 4 -
수침콩(실시예 4)과 발아콩(실시예 5)을 폴리스티렌 발효용기에 각각 200g씩 담아 121℃에서 30분 증자한 후 상온으로 냉각시켜 종균 배양한 까치버섯 균사체 배양액을 5%(v/w) 접종하였다. 콩 고체발효는 25℃에서 8일간 발효시켜 사용하였다.200 g of each of the soymilk beans (Example 4) and the sprouted beans (Example 5) were placed in a polystyrene fermentation vessel, and the mixture was incubated at 121 DEG C for 30 minutes, cooled to room temperature, ). The soybean solid fermentation was used for fermentation at 25 ℃ for 8 days.
콩의 대표적인 고체발효법으로 제조되어 널리 식품으로 사용하고 있는 청국장을 대조구(비교예 2)로 사용하였다. 청국장 역시 노란콩(폼종명: 대원콩)을 12시간 수침한 후 물기를 제거하고 121℃에서 30분간 증자처리 하였다. 이후 상온으로 적당히 식힌 후 미리 배양해 놓은 Bacillus amyloliquefaciens 2TDJ15 균주배양액을 전체 무게의 5% 접종하고 37℃에서 3일간 발효시켜 제조하였다. 발효가 완료된 까치버섯 균사체 콩발효물과 청국장은 50℃에서 3일 건조한 후 분쇄기로 분쇄하여 분말을 제조하였다(도 4).Chungkookjang, which is produced by a typical solid fermentation method of soybean and widely used as food, was used as a control (Comparative Example 2). Chungkukjang was also soaked with yellow soybeans (foam name: Daewon bean) for 12 hours, and then the water was removed and treated at 121 ° C for 30 minutes. After cooling to room temperature, Bacillus inoculated 2TDJ15 amyloliquefaciens strain culture solution 5% of the total weight, which was produced by fermentation in 37
실험예Experimental Example 1. 지방산과 1. Fatty acids and 공액리놀레산Conjugated linoleic acid 함량 content
상기 실시예 4 및 5에서 제조된 청국장 분말, 까치버섯 균사체 발아콩 발효물 분말 및 까치버섯 균사체 수침콩 발효물 분말의 지방산과 공액리놀렌산 함량을 분석하였다.The fatty acid and conjugated linolenic acid contents of the chungkukjang powder, the shiitake mushroom mycelia germinated fermented powder and the shodoshin mushroom fermented soybean powder prepared in Examples 4 and 5 were analyzed.
<지방산 분석><Fatty Acid Analysis>
지방산은 상기의 시험예 1과 동일하게 지방산 분석 방법에 준하여 수행하였다. The fatty acid was carried out according to the fatty acid analysis method in the same manner as in Test Example 1 above.
청국장(비교예 2), 까치버섯 균사체 수침콩 발효물(실시예 4) 및 까치버섯 균사체 발아콩 발효물(실시예 5) 분말의 지방산 함량은 표 2와 같다. 총 지방산 함량은 까치버섯 균사체 수침콩발효물 분말 > 청국장 분말 > 까치버섯 균사체 발아콩발효물 분말 순이었다. 표 2는 청국장과 까치버섯 균사체 콩발효물 분말의 지방산 조성 비교한 것을 나타낸다.The fatty acid content of the fermented soybean fermented product (Example 4) and the fermented product of germinated fermented soybean curd mushroom (Example 5) are shown in Table 2. Total fatty acid contents were as follows: Shiitake mushroom mycelium soaking fermented soybean powder> Chungkukjang powder> Magpie mushroom mycelium germination fermented soybean powder. Table 2 shows the comparison of fatty acid composition of soybean fermented powder of Chongkukjang and Shokuchishi mushroom mycelium.
지방산 함량
(mg/100 g)
Fatty acid content
(mg / 100 g)
청국장 분말
(비교예 2)
Chungkookjang powder
(Comparative Example 2)
까치버섯 균사체 콩발효물 분말
Mushroom mycelia soybean fermented water powder
(수침콩)Example 4
(Soymilk)
(발아콩)Example 5
(Sprouted beans)
**nd; 검출되지 않음* All experiments were repeated three times
** nd; Not detected
<공액리놀렌산 분석>≪ Analysis of conjugated linolenic acid &
상기 실시예 4 및 5에서 제조된 청국장(비교예 2), 까치버섯 균사체 수침콩발효물(실시예 4) 및 까치버섯 균사체 발아콩발효물(실시예 5) 분말의 공액리놀렌산 함량은 표 3과 같다. 청국장 분말에서는 공액리놀렌산이 검출되지 않았고, 까치버섯 균사체 수침콩발효물 분말 및 까치버섯 균사체 발아콩발효물 분말의 총 공액리놀렌산 함량은 각각 55.22μg/g 및 50.68μg/g을 나타내었다. 표 3은 청국장과 까치버섯 균사체 콩발효물 분말의 공액리놀레산 함량 비교한 것을 나타낸다.The content of conjugated linolenic acid in the fermented soybean curd (Comparative Example 2), the fermented soybean curd submerged fermented soybean soybean (Example 4) and the fermented soybean fermented soybean curd subbed (Example 5) prepared in Examples 4 and 5, same. Conjugated linolenic acid was not detected in chungkukjang powder, and the total conjugated linolenic acid contents of fermented soybean curd flour and soybean curd fungus fermented powder were 55.22 μg / g and 50.68 μg / g, respectively. Table 3 shows a comparison of the content of conjugated linoleic acid in soybean fermented product powder of Chongkukjang and Shokuchishi mushroom mycelium.
공액리놀렌산 함량
(μg/g)
Conjugated linolenic acid content
(μg / g)
청국장 분말
(비교예 2)
Chungkookjang powder
(Comparative Example 2)
까치버섯 균사체 콩발효물 분말
Mushroom mycelia soybean fermented water powder
(수침콩)Example 4
(Soymilk)
(발아콩)Example 4
(Sprouted beans)
**nd; 검출되지 않음* All experiments were repeated three times
** nd; Not detected
실험예Experimental Example 2. 총 2. Total 페놀릭스Phenolics 및 이소플라본 함량 And isoflavone content
상기 실시예 4 및 5에서 제조된 청국장 분말, 까치버섯 균사체 수침콩발효물 분말 및 까치버섯 균사체 발아콩발효물 분말의 지방산과 공액리놀렌산 함량을 분석하였다.The fatty acid and conjugated linolenic acid contents of the chungkukjang powder, the shag mushroom soymilk fermented soybean powder and the shiitake mushroom fermented soybean powder prepared in Examples 4 and 5 were analyzed.
<추출물 제조><Preparation of extract>
청국장 분말, 까치버섯 균사체 수침콩발효물 분말 및 까치버섯 균사체 발아콩발효물 분말 10g을 정확히 칭량한 후 50% 메탄올 10mL를 가하고 300rpm으로 상온에서 12시간 추출하였다. 추출액을 20분간 원심분리한 후 상등액을 0.45μm 필터로 여과하여 추출물을 제조하였으며 총 페놀릭스 및 이소플라본 함량 분석에 사용하였고 나머지는 필요에 따라 농축건조하여 0.5mg/ml 및 1.0mg/ml 농도로 조정하여 항산화 활성과 소화효소 저해활성에 사용하였다. 10 g of fermented soybean powder, 10 g of fermented soybean fermented soybean powder, and 10 g of 50% methanol were added thereto, followed by extraction at 300 rpm at room temperature for 12 hours. The extract was centrifuged for 20 minutes and then the supernatant was filtered with a 0.45 μm filter to prepare an extract. The extract was used for the analysis of total phenolics and isoflavones. The remainder was concentrated and dried at 0.5 mg / ml and 1.0 mg / ml Were used for antioxidant activity and digestive enzyme inhibitory activity.
<총 페놀릭스 분석>≪ Analysis of total phenolics >
총 페놀릭스 함량은 Folin과 Denis(1912)의 방법에 준하여 측정하였다. 각각의 추출물을 시험관에 0.5 mL 분주한 뒤 25% Na2CO3 용액 0.5 mL를 첨가하여 3분간 정치시켰으며 이후 2 N-Folin-Ciocalteu phenol을 0.25 mL를 첨가하여 혼합한 다음 30℃에서 1시간 동안 발색시켜 750nm에서 흡광도를 측정하였으며 gallic acid을 이용하여 미리 작성한 표준곡선으로부터 gallic acid에 상당하는 양(GAE mg/g)으로 계산하였고, 그 결과를 표 4에 나타내었다. Total phenolic content was measured by Folin and Denis (1912). 0.5 mL of each extract was placed in a test tube, and 25% Na 2 CO 3 And then incubated for 3 minutes. Then, 0.25 mL of 2 N-Folin-Ciocalteu phenol was added and mixed. The mixture was developed at 30 ° C for 1 hour, and the absorbance at 750 nm was measured. Using gallic acid, (GAE mg / g) from the curve, and the results are shown in Table 4.
청국장 분말(비교예 2)은 11.67mg/g으로 까치버섯 균사체 콩발효물 보다는 함량이 낮았다. 까치버섯 균사체 수침콩발효물 분말 및 까치버섯 균사체 발아콩발효물 분말의 총 페놀릭스 함량은 각각 12.07 mg/g 및 13.05 mg/g을 나타내었다. 표 4는 청국장과 까치버섯 균사체 콩발효물 분말의 총 페놀릭스 함량 비교한 것을 나타낸다.The content of chungkukjang powder (Comparative Example 2) was 11.67 mg / g, which was lower than that of soybean fermented soybean curd mushroom. Total phenolic contents of the fermented soybean fermented soybean powder and the fermented soybean fermented soybean powder were 12.07 mg / g and 13.05 mg / g, respectively. Table 4 shows the total phenolic content of soybean fermented powder of Chungkukjang and Shokuchishi mushroom mycelium.
총 페놀릭스 함량
(mg/g)
Total phenolic content
(mg / g)
청국장 분말
(비교예 2)
Chungkookjang powder
(Comparative Example 2)
까치버섯 균사체 콩발효물 분말
Mushroom mycelia soybean fermented water powder
(수침콩)Example 4
(Soymilk)
(발아콩)Example 5
(Sprouted beans)
<이소플라본 분석>≪ Isoflavone analysis >
이소플라본 분석은 Cho 등(2011)의 방법에 준하여 HPLC로 분석하였다. 분석 column은 Lichrophore 100 RP C18 column(4.6mm, 5 μm, Merck, Germany)을 사용하였고 이동상 용매는 0.2% acetic acid in water(이동상 A)와 0.2% acetic acid in water(이동상 B)로 분석하였다. 이동상 조건으로는 A 용매 기준으로 0분-100%, 15분-90%, 25분-80%, 35분-75%, 45분-65% 및 50분-65%로 유지시켰다. 시료는 각각의 추출물 20 μL를 주입하였으며 이동상 속도는 30℃에서 1 mL/min로 유지하였다. 검출기는 diode array detector(Agilent 1200 series, Agilent Co.)를 사용하였으며 UV 254 nm에서 정량하였다.Isoflavone analysis And analyzed by HPLC according to the method of Cho et al. (2011). The analytical column was analyzed using a
청국장 분말, 까치버섯 균사체 수침콩발효물 분말 및 까치버섯 균사체 발아콩발효물 분말의 총 이소플라본 함량은 각각 1,583.88 ㎍/g, 1,681.8 ㎍/g 및 1,418.84 ㎍/g 있었으며, 청국장 분말보다 까치버섯 균사체 콩발효물이 비배당체-이소플라본 함량이 훨씬 높았다. 특히, 까치버섯 균사체 발아콩발효물(실시예 5)의 경우 배당체-이소플라본 비율은 20.1%와 비배당체-이소플라본 비율은 79.9%로 청국장 분말(비교예 2: 배당체-이소플라본 비율 85.2%와 비배당체-이소플라본 비율 14.8%)과 비교하여 반대 양상을 나타내고 있다(표 4 및 도 5). 표 5는 청국장과 까치버섯 균사체 콩발효물 분말의 이소플라본 함량 비교한 것을 나타낸다.The total isoflavone contents of the fermented powder of Chongkukjang powder, Shoku mushroom mycelia, and soaked fermented soybean powder were 1,583.88 ㎍ / g and 1,681.8 ㎍ / g and 1,418.84 ㎍ / g, respectively. The fermented product had much higher unglycosylated - isoflavone content. Particularly, in the case of the fermented germinating soybean mycelia (Example 5), the ratio of glycoside to isoflavone was 20.1% and that of non-glycoside to isoflavone was 79.9% Non-glycoside-isoflavone ratio of 14.8%) (Table 4 and Figure 5). Table 5 shows the isoflavone content of soybean fermented product powder of Chungkukjang and Shokuchishi mushroom mycelium.
이소플라본 함량 (μg/g) /
비율 (%)
Isoflavone content (μg / g) /
ratio (%)
청국장 분말
(비교예 2)
Chungkookjang powder
(Comparative Example 2)
까치버섯 균사체 콩발효물 분말
Mushroom mycelia soybean fermented water powder
(수침콩)Example 4
(Soymilk)
(발아콩)Example 5
(Sprouted beans)
**nd; 검출되지 않음* All experiments were repeated three times
** nd; Not detected
실험예Experimental Example 3. 3. 유리아미노산Free amino acid 및 암모니아 함량 And ammonia content
상기 실시예 4 및 5에서 제조된 청국장 분말, 까치버섯 균사체 발아콩발효물 분말 및 까치버섯 균사체 수침콩발효물 분말의 유리아미노산과 암모니아 함량을 분석하였다.Free amino acid and ammonia contents of the chungkukjang powder, the shiitake mushroom mycelia germinated fermented powder and the shodoshin mushroom mycelial fermented soybean powder prepared in Examples 4 and 5 were analyzed.
<유리아미노산 및 암모니아 분석>≪ Free Amino Acid and Ammonia Analysis >
유리아미노산과 암모니아 분석은 식품공전법에 준하여 분말 0.1 g을 시험관에 취하고 HPLC water를 5 mL를 가하여 60℃에서 1시간 가수분해를 진행한 후 10% salicylic acid 1 mL를 각각의 시료에 첨가하여 2시간 방치시켜 단백질을 침전시켰다. 이후에는 glass filter로 여과한 여액을 감압 농축하여 수분을 제거하고 lithium citrate buffer(pH 2.2) 2mL로 용해한 후 0.2μm membrane filter(Dismic-25CS, Toyoroshikaisha Ltd., Tokyo, Japan)로 여과한 여액을 아미노산 자동분석기를 이용하여 분석하였고, 그 결과를 표 5와 도 6에 나타내었다.For analysis of free amino acid and ammonia, 0.1 g of powder was taken into a test tube according to the Food Ordinance method, 5 mL of HPLC water was added, and hydrolysis was carried out at 60 ° C. for 1 hour. 1 mL of 10% salicylic acid was added to each sample to obtain 2 The protein was allowed to settle for a time. The filtrate was filtered with a 0.2 μm membrane filter (Dismic-25CS, Toyoroshikaisha Ltd., Tokyo, Japan). The filtrate was dissolved in 2 ml of lithium citrate buffer (pH 2.2) The results were analyzed using an automatic analyzer, and the results are shown in Table 5 and FIG.
청국장 분말, 까치버섯 균사체 수침콩발효물 분말 및 까치버섯 균사체 발아콩발효물 분말의 총 아미노산 함량은 각각 1,580.29mg/100g, 1,580.5mg/100g 및 1,886mg/100g으로 나타났다. The total amino acid contents of chungkukjang powder, shrike mushroom mycelia sole fermented water powder and shawn mushroom mycelia germinated fermented powder were 1,580.29mg / 100g, 1,580.5mg / 100g and 1,886mg / 100g, respectively.
한편, 단백질 발효식품의 경우 발효취 즉 악취 발생의 주요 요인 암모니아 함량의 경우 청국장 분말(암모니아 함량: 112.81mg/100g)보다는 까치버섯 균사체 콩발효물(수침콩: 25.52mg/100g 및 26.17mg/100g)이 훨씬 낮은 함량은 나타내어 청국장 분말보다 다양한 가공식품 개발이 가능하다. 표 6은 청국장과 까치버섯 균사체 콩발효물 분말의 아미노산과 암모니아 함량 비교한 것을 나타낸다.In the case of protein fermented foods, fermented soybean fermented soybean fermented soybean (25.52 mg / 100 g and 26.17 mg / 100 g) was the main factor of the occurrence of odor in the case of ammonia content than that of chungkukjang powder (ammonia content: 112.81 mg / ), Which is much lower than that of Chungkukjang powder. Table 6 shows the amino acid and ammonia content of soybean fermented powder of Chungkukjang and Shark mushroom mycelium.
아미노산 함량
(㎎/100 g)
Amino acid content
(Mg / 100 g)
청국장
(비교예 2)
Cheonggukjang
(Comparative Example 2)
까치버섯 균사체 콩발효물
Fermented soybean curd mycelium
(수침콩)Example 4
(Soymilk)
(발아콩)Example 5
(Sprouted beans)
**nd; 검출되지 않음* All experiments were repeated three times
** nd; Not detected
실험예Experimental Example 4. 항산화 활성 4. Antioxidant activity
상기 실시예 4 및 5에서 제조된 청국장 분말, 까치버섯 균사체 발아콩발효물 분말 및 까치버섯 균사체 수침콩발효물 분말의 DPPH 라디칼 소거활성, ABTS 라디칼 소거활성 및 OH 라디칼 소거활성으로 항산화 활성을 분석하였다. 표 7은 청국장과 까치버섯 균사체 콩발효물 분말의 항산화 활성 비교한 것을 나타낸다.The DPPH radical scavenging activity, the ABTS radical scavenging activity, and the antioxidative activity of the fermented powder of chrysanthemum powder, shiitake mushroom germination fermented product and shag mushroom mycelium prepared in Examples 4 and 5 The antioxidative activity was analyzed by OH radical scavenging activity. Table 7 shows the comparison of antioxidative activities of soybean fermented powder of Chongkukjang and Shoku mushroom mycelium.
라디칼 소거활성
(%)
Radical scavenging activity
(%)
청국장 분말
(비교예 4)
Chungkookjang powder
(Comparative Example 4)
까치버섯 균사체 콩발효물 분말
Mushroom mycelia soybean fermented water powder
(수침콩)Example 2
(Soymilk)
(발아콩)Example 3
(Sprouted beans)
**처리농도: 0.5 mg/ml* All experiments were repeated three times
** Treatment concentration: 0.5 mg / ml
<DPPH 라디칼 소거활성>≪ DPPH radical scavenging activity >
DPPH 라디칼 소거활성은 Blois(1958)의 방법에 따라 측정하였다. 10- 4mM DPPH 용액 0.8mL와 추출물 0.2mL를 가하여 30분간 암실에서 반응시킨 후 분광광도계를 이용하여 525nm에서 흡광도를 측정하였다. 음성 대조구 실험은 시료 대신에 에탄올을 0.2mL를 취하여 실험하였으며, DPPH 라디칼 소거활성은 실험구와 음성 대조구의 흡광도를 구하여 상대적 비교치(%)로 나타내었다. The DPPH radical scavenging activity was measured according to the method of Blois (1958). 0.8 ml of 10 - 4 mM DPPH solution and 0.2 ml of extract were added and reacted in a dark room for 30 minutes. Absorbance was measured at 525 nm using a spectrophotometer. In the negative control experiment, 0.2 mL of ethanol was used instead of the sample, and the DPPH radical scavenging activity was expressed as a relative value (%) of the absorbance of the experimental group and the negative control.
청국장 분말(비교예 2) 보다는 까치버섯 균사체 콩발효물 분말이 활성이 높았으나, 발아콩이 더 뛰어난 활성을 나타내었다. 즉, 청국장 분말은 52.49%와 까치버섯 균사체 수침콩발효물 분말은 58.74% 보다는 까치버섯 균사체 발아콩발효물 분말이 62.49%로 좀 더 우수한 DPPH 라디칼 소거활성을 나타내었다(표 7).The fermented powder of soybean fermented mushroom mycelia showed higher activity than that of chungkukjang powder (Comparative Example 2), but germinated soybean showed more excellent activity. In other words, 52.49% of Chungkukjang powder and 62.49% of Shung-mushroom mycelia germinated fermented powder showed more DPPH radical scavenging activity than the 58.74% of Shung mushroom mycelium sole fermented powder (Table 7).
<ABTS 라디칼 소거활성> <ABTS radical scavenging activity>
7mM ABTS 용액과 2.45 mM potassium persulfate를 1:1(v/v)로 섞고, 암실에서 12~16시간을 방치시켜 ABTS 라디칼(ABTS+)을 형성시켰다. 이후 732nm에서 흡광도 값이 0.7이 되도록 메탄올로 희석하여 사용하였다. 적당히 희석된 ABTS 용액 0.9mL와 추출물 0.1mL를 섞고 3분 후 분광광도계를 이용하여 732nm에서 흡광도를 측정하였다. 음성 대조구 실험은 시료 대신에 메탄올을 0.1mL를 취하여 실험하였으며, ABTs 라디칼 소거활성은 상기 기술된 DPPH 라디칼 소거활성과 동일한 방법으로 나타내었다.The ABTS radicals (ABTS + ) were formed by mixing 7 mM ABTS solution and 2.45 mM potassium persulfate in 1: 1 (v / v) and left for 12 ~ 16 hours in the dark room. And then diluted with methanol to obtain an absorbance value of 0.7 at 732 nm. 0.9 mL of the appropriately diluted ABTS solution and 0.1 mL of the extract were mixed and the absorbance was measured at 732 nm using a spectrophotometer after 3 minutes. In the negative control experiment, 0.1 mL of methanol was used instead of the sample, and the ABTs radical scavenging activity was shown in the same manner as the DPPH radical scavenging activity described above.
ABTS 라디칼 소거활성 역시 청국장 분말(비교예 2)보다는 까치버섯 균사체 콩발효물 분말이 활성이 높았으나, 발아콩이 더 뛰어난 활성을 나타내었다(표 7). The ABTS radical scavenging activity was also higher in the soybean fermented powder than in the chungkukjang powder (Comparative Example 2), but the germinated soybean showed more excellent activity (Table 7).
<OH 라디칼 소거활성>< OH radical scavenging activity>
10 mM FeSO4 .7H2O-EDTA 0.2mL, 10mM 2-deoxyribose 0.2mL, 10mM H2O2 0.2mL, 시료 1.4mL를 혼합한 뒤 37℃에서 4시간 동안 반응시켰다. 이 혼합액에 1% thiobarbituric acid와 2.8% trichloroaceric acid를 각각 1mL를 가하여 100℃에서 20분간 가열하고 냉각시킨 후 520nm에서 흡광도를 측정하였다. 음성 대조구 실험은 시료 대신에 PBS 완충액(NaCl 8.76g, NaH2PO4 0.11g, Na2HPO4 0.596g)을 사용하였다. hydroxyl radical 소거활성은 시료용액의 첨가구와 무 첨가구 사이의 흡광도 차이를 백분율(%)로 나타내었다(Adjimani 및 Asare, 2015).10 mM FeSO 4. 0.2 mL of 7H 2 O-EDTA, 0.2 mL of 10 mM 2-deoxyribose, 0.2 mL of 10 mM H 2 O 2 , and 1.4 mL of a sample were mixed and reacted at 37 ° C. for 4 hours. 1 ml of 1% thiobarbituric acid and 2.8% trichloroaceric acid were added to the mixture, and the mixture was heated at 100 ° C for 20 minutes, cooled, and absorbance was measured at 520 nm. In the negative control experiment, PBS buffer solution (8.76 g NaCl, 0.11 g NaH 2 PO 4 , 0.596 g Na 2 HPO 4 ) was used instead of the sample. The hydroxyl radical scavenging activity was expressed as a percentage (%) of the absorbance difference between the addition of the sample solution and the addition of the sample solution (Adjimani and Asare, 2015).
OH 라디칼 소거활성 청국장 분말(비교예 2)은 52.62%로 까치버섯 균사체 콩발효물 분말이 활성이 낮았고, 까치버섯 균사체 발아콩발효물 분말이 72.99%로 가장 높은 활성을 나타내었다(표 7). The activity of the radish scavenging active chungkukjang powder (Comparative Example 2) was 52.62%, the activity of the soybean fermented powder of the magpie mushroom was low, and the fermented powder of the germinated fermented soybean curd mushroom showed the highest activity of 72.99% (Table 7).
실험예Experimental Example 5. 소화효소 저해 활성 5. Digestive enzyme inhibitory activity
상기 실시예 4 및 5에서 제조된 청국장 분말, 까치버섯 균사체 발아콩발효물 분말 및 까치버섯 균사체 수침콩발효물 분말의 알파-글루코시다아제 저해활성 및 췌장 리파아제 저해활성으로 탄수화물과 지방 소화효소 저해활성을 분석하였다. 표 8는 청국장과 까치버섯 균사체 콩발효물 분말의 소화효소 저해활성 비교한 것을 나타낸다. The alpha-glucosidase inhibitory activity and the pancreatic lipase inhibitory activity of the fermented powder of chongkukjang powder, shiitake mushroom mycelia germinated soybean fermented product and shrike mushroom mycelial sole prepared in Examples 4 and 5, and carbohydrate and lipid digestive enzyme inhibitory activity Respectively. Table 8 shows the digestive enzyme inhibitory activity of soybean fermented powder of Chongkukjang and Shokuchishi mycelia.
소화효소 저해활성
(μg/g)
Digestive enzyme inhibitory activity
(μg / g)
청국장 분말
(비교예 2)
Chungkookjang powder
(Comparative Example 2)
까치버섯 균사체 콩발효물 분말
Mushroom mycelia soybean fermented water powder
(수침콩)Example 4
(Soymilk)
(발아콩)Example 5
(Sprouted beans)
**처리농도: 1.0 mg/ml* All experiments were repeated three times
** Treatment concentration: 1.0 mg / ml
<알파-글루코시다아제 저해활성>≪ Alpha-Glucosidase Inhibitory Activity >
각각의 추출물 30μL에 0.5 U/mL alpha-glucosidase 효소액 70μL를 첨가하고 여기에 200mM 인산나트륨 완충액(pH 6.8) 50μL 혼합하여 37℃에서 10분간 예비 배양한 후, 10mM이 되게 p-NPG(p-nitrophenyl butyrate)를 녹인 인산나트륨 완충액(pH 6.8)을 100μL 가하여 37℃에서 10분간 반응시켰다. 그 후 반응액에 100 mM Na2CO3 750mL를 첨가하여 반응을 정지시키고 420nm에서 흡광도를 측정하였다. 음성 대조구 실험은 시료 대신에 추출 용매로 실험하였다. To each 30 μL of each extract, 70 μL of 0.5 U / mL alpha-glucosidase enzyme solution was added, and 50 μL of 200 mM sodium phosphate buffer (pH 6.8) was mixed and preliminarily incubated at 37 ° C. for 10 minutes. Then, p -NPG ( p- nitrophenyl butyrate was dissolved in 100 μL of sodium phosphate buffer solution (pH 6.8), and the mixture was reacted at 37 ° C. for 10 minutes. Then, 750 mL of 100 mM Na 2 CO 3 was added to the reaction solution to stop the reaction and the absorbance at 420 nm was measured. Negative control experiments were conducted with extraction solvents instead of samples.
청국장 분말(비교예 2)보다는 까치버섯 균사체 콩발효물 분말이 활성이 높았고, 발아콩이 가장 높은 활성을 나타내었다. 즉, 청국장 분말은 85.49%와 까치버섯 균사체 수침콩발효물 분말은 92.64% 보다는 까치버섯 균사체 발아콩발효물 분말이 94.55%로 좀 더 우수한 DPPH 라디칼 소거활성을 나타내었다(표 8).The activity of soybean fermented powder of Cryptomeria japonica was higher than that of Chungkookjang powder (Comparative Example 2), and germinated soybean showed the highest activity. In other words, 85.49% of Chungkukjang powder and 94.55% of Shung-mushroom mycelia germinated fermented powder showed 92% higher DPPH radical scavenging activity than 92.64% of Shiitake mushroom mycelium sole fermented powder (Table 8).
<췌장 리파아제 저해활성><Pancreatic Lipase Inhibitory Activity>
각각의 추출물 50μL와 0.5U/mL lipase 효소 50μL를 200mM 인산나트륨 완충액 50μL를 혼합하여 37℃에서 10분간 예비 배양한 후, 10 mM이 되게 p-NPG를 녹인 인산나트륨 완충액을 100μL를 가하여 37℃에서 10분간 반응시켰다. 반응액에 100 mM Na2CO3 750mL를 첨가하여 반응을 정지시키고 420nm에서 흡광도를 측정하였다. 음성 대조구 실험은 시료 대신에 추출 용매로 실험하였다. 50 μL of each extract and 50 μL of 0.5 U / mL lipase enzyme were mixed with 50 μL of 200 mM sodium phosphate buffer, preliminarily cultured at 37 ° C. for 10 minutes, 100 μL of sodium phosphate buffer dissolved in p -NPG to 10 mM, The reaction was carried out for 10 minutes. The reaction was stopped by adding 750 mL of 100 mM Na 2 CO 3 to the reaction solution, and the absorbance was measured at 420 nm. Negative control experiments were conducted with extraction solvents instead of samples.
췌장 리파아제 저해활성 역시 청국장 분말(비교예 2)보다는 까치버섯 균사체 콩발효물 분말이 활성이 높았으나, 발아콩이 더 뛰어난 활성을 나타내었다(표 8). The pancreatic lipase inhibitory activity was also higher in the soybean fermented powder of the black mushroom mycelium than in the chungkukjang powder (Comparative Example 2), but the germinated soybean showed more excellent activity (Table 8).
실험예Experimental Example 6. 기호성 평가 6. Evaluation of palatability
상기 실시예 4 및 5에서 제조된 청국장 분말, 까치버섯 균사체 발아콩발효물 분말 및 까치버섯 균사체 수침콩발효물 분말의 기호성 평가는 기호성 평가의 목적, 시료 등에 대해서 우선 시험자들에게 사전 인지시킨 후 1차적인 기호성 평가가 실시를 통하여 최종 선별력이 우수한 성마리오식품 직원 3명과 경남과학기술대학교 식품과학부 재학생 20명을 대상으로 ‘매우 좋다 5점, 좋다 4점, 보통이다 3점, 나쁘다 2점 및 매우 나쁘다 1점’으로 하는 5점 척도법으로 평가하였다.The palatability evaluation of the cheonggukjang powder, the shiitake mushroom mycelia germination fermented product powder and the shodoshin mushroom mycelia sole fermented product powder prepared in Examples 4 and 5 was firstly recognized for the purpose of palatability evaluation and samples, The results of this study were as follows: First, three excellent Stallmario food staffs and 20 students from Kyungnam University of Science and Technology were selected as excellent 5, good 4,
기호성 평가 결과는 표 9에 나타내었으며, 색깔은 거의 유사한 점수를 획득하였으나, 청국장 분말보다는 까치버섯 균사체 발아콩발효물 분말이 악취, 향, 맛 및 기호도 측면에서 모두 우수한 것으로 나타났다. 특히 악취의 경우 청국장 분말은 단백질 발효식품 특유의 암모니아 냄새가 까치버섯 균사체 수침콩발효물 분말보다는 심한 것으로 나타났다. 표 9는 청국장과 까치버섯 균사체 콩발효물 분말의 기호성 비교한 것을 나타낸다.The results of the palatability evaluation are shown in Table 9, and the color was almost similar, but the fermented powder of germinated soybean curd mushroom mycelium was superior to that of chongkukjang powder in terms of odor, flavor, taste and taste. Especially, in the case of odor, the ammonia odor characteristic of protein fermented food was more severe than that of soaked mushroom mycelia sole fermented powder. Table 9 shows a comparison of the palatability of soybean fermented product powder of Chongkukjang and Shoku mushroom mycelium.
기호성 평가 항목
Purity evaluation item
청국장 분말
(비교예 2)
Chungkookjang powder
(Comparative Example 2)
까치버섯 균사체 콩발효물 분말
Mushroom mycelia soybean fermented water powder
(수침콩)Example 4
(Soymilk)
(발아콩)Example 5
(Sprouted beans)
**처리농도: 1.0 mg/ml* All experiments were repeated three times
** Treatment concentration: 1.0 mg / ml
이상으로 본 발명의 특정한 부분을 상세히 기술하였으나, 당업계의 통상의 지식을 가진 자에게 있어 이러한 구체적인 기술은 단지 바람직한 구현의 예일 뿐이며, 이에 본 발명의 범위가 제한되는 것이 아닌 점은 명백하다. 따라서 본 발명의 실질적인 범위는 첨부된 청구항과 그의 균등물에 의하여 정의된다고 할 것이다.Although specific portions of the present invention have been described in detail, those skilled in the art will appreciate that these specific embodiments are merely examples of preferred embodiments and that the scope of the present invention is not limited thereto. It is therefore intended that the scope of the present invention be defined by the appended claims and their equivalents.
Claims (16)
증자시킨 콩을 포함하는, 버섯에 의해 고체 발효된 콩발효물.
At least one of at least one of mushroom mycelium and culture thereof selected from magpie mushroom, pine mushroom, and mushroom; And
Fermented soybean fermented solid by mushroom, including soybeans added.
공액리놀레산 및 비배당체 이소플라본 함량 중 적어도 하나 이상이 증대된, 버섯에 의해 고체 발효된 콩발효물.
The method according to claim 1,
A fermented soybean fermented by mushroom solid fermentation, wherein at least one of the contents of the conjugated linoleic acid and the non-glycoside isoflavone is increased.
암모니아 함량이 감소하고 풍미가 개선된, 버섯에 의해 고체 발효된 콩발효물.
The method according to claim 1,
Fermented soybean fermented solid by mushroom, with reduced ammonia content and improved flavor.
상기 콩은 수침콩 또는 발아콩인, 버섯에 의해 고체 발효된 콩발효물.
The method according to claim 1,
The soybean is a fermented soybean which is solid-fermented by mushroom, which is soaked bean or germinated soybean.
A food comprising the soybean fermented product according to any one of claims 1 to 4.
상기 식품은 분말, 과립, 편상(flake), 페이스트, 시럽, 겔, 젤리, 바(bar), 환(pill), 정제(tablet), 캡슐, 및 액상 중에서 선택되는 형태로 가공된, 식품.
6. The method of claim 5,
Wherein the food is processed into a form selected from a powder, a granule, a flake, a paste, a syrup, a gel, a jelly, a bar, a pill, a tablet, a capsule and a liquid.
항산화 활성, 당뇨 또는 비만의 예방 또는 개선 효과가 있는 기능성 식품인, 식품.
6. The method of claim 5,
Antioxidant activity, diabetes, or obesity.
상기 콩을 발효시키는 발효단계를 포함하는 콩의 고체 발효 방법.
An inoculation step of inoculating the soybean to which at least one of mushroom mycelia selected from mushroom mushroom, mushroom mushroom, and mushroom and at least one of the cultures thereof is added; And
And a fermentation step of fermenting the soybean.
상기 콩을 발효시키는 발효단계를 포함하는 콩발효물의 제조 방법.
An inoculation step of inoculating the soybean to which at least one of mushroom mycelia selected from mushroom mushroom, mushroom mushroom, and mushroom and at least one of the cultures thereof is added; And
And a fermentation step of fermenting the soybean.
상기 접종단계에서 콩을 증자하기 전에 수침하거나 발아시키는 단계를 더 포함하는, 방법.
10. The method according to claim 8 or 9,
Further comprising soaking or germinating the soybeans before the soybean is grown in said seeding step.
상기 접종단계에서 버섯 균사체 또는 그 배양물은 콩 중량에 대해 5~10 중량부로 접종하는, 방법.
10. The method according to claim 8 or 9,
Wherein the mushroom mycelium or the culture thereof is inoculated in an amount of 5 to 10 parts by weight based on the weight of the soybean.
상기 접종단계 이전에 버섯을 상온에서 4~6일간 배양하는 단계를 더 포함하는, 방법.
10. The method according to claim 8 or 9,
Further comprising culturing the mushroom at room temperature for 4 to 6 days prior to the inoculating step.
상기 발효단계는 20~30℃에서 5~ 10일간 발효시키는, 방법.
10. The method according to claim 8 or 9,
Wherein the fermentation step is performed at 20 to 30 DEG C for 5 to 10 days.
상기 발효단계 후 건조 후 분말화 시키는 단계를 더 포함하는, 방법.
10. The method according to claim 8 or 9,
Further comprising drying and pulverizing after the fermentation step.
상기 분말화 시키는 단계는 발효된 콩을 45~55℃에서 2~3일간 건조하는 단계를 포함하는, 방법.
15. The method of claim 14,
Wherein the pulverizing comprises drying the fermented soybeans at 45 to 55 DEG C for 2 to 3 days.
상기 발효단계 후 콩발효물을 분말, 과립, 편상(flake), 페이스트, 시럽, 겔, 젤리, 바(bar), 환(pill), 정제(tablet), 캡슐, 및 액상으로 제형화하는 단계를 더 포함하는, 방법.10. The method according to claim 8 or 9,
The step of formulating the soybean fermented product into a powder, a granule, a flake, a paste, a syrup, a gel, a jelly, a bar, a pill, a tablet, a capsule and a liquid after the fermentation step ≪ / RTI >
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160140273A KR101993777B1 (en) | 2016-10-26 | 2016-10-26 | Solid fermented soybean with mushroom and method for preparation thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160140273A KR101993777B1 (en) | 2016-10-26 | 2016-10-26 | Solid fermented soybean with mushroom and method for preparation thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20180045658A true KR20180045658A (en) | 2018-05-04 |
KR101993777B1 KR101993777B1 (en) | 2019-07-01 |
Family
ID=62199350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160140273A KR101993777B1 (en) | 2016-10-26 | 2016-10-26 | Solid fermented soybean with mushroom and method for preparation thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101993777B1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200013327A (en) * | 2018-07-30 | 2020-02-07 | 대구한의대학교산학협력단 | Food composition for anti-oxidant and anti-inflammatory comprising extract of fermented soybean and preparation method thereof |
KR20200060000A (en) * | 2018-11-22 | 2020-05-29 | 우석대학교 산학협력단 | Fermented soybean milk food with sprouted bean and process for preparing the same |
KR20200091788A (en) * | 2019-10-24 | 2020-07-31 | 허서진 | Method for preparing powder of mycelium using mushroom medium and grain fermentation powder |
KR20220051584A (en) * | 2020-10-19 | 2022-04-26 | 경상국립대학교산학협력단 | Fermentation composition of mountain-cultivated ginseng having increased ginsenoside Rd, Rc and Protopanaxadiol by using Tricholoma matsutake mycelium and preparation method thereof |
WO2022091089A1 (en) * | 2020-10-28 | 2022-05-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Food products comprising fungal mycelium, process for their preparation and uses thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990037854A (en) * | 1999-02-04 | 1999-05-25 | 이순금 | The manufacture method of MEJU |
KR20140066136A (en) * | 2014-04-28 | 2014-05-30 | 대한민국(농촌진흥청장) | Use of microorganism for preparing conjugated linoleic acid and food containing it |
KR20170055356A (en) * | 2015-11-11 | 2017-05-19 | 대한민국(농촌진흥청장) | soybean meat containing large quantity of conjugated linoleic acid and isoflavone and manufacturing method thereof |
-
2016
- 2016-10-26 KR KR1020160140273A patent/KR101993777B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990037854A (en) * | 1999-02-04 | 1999-05-25 | 이순금 | The manufacture method of MEJU |
KR20140066136A (en) * | 2014-04-28 | 2014-05-30 | 대한민국(농촌진흥청장) | Use of microorganism for preparing conjugated linoleic acid and food containing it |
KR20170055356A (en) * | 2015-11-11 | 2017-05-19 | 대한민국(농촌진흥청장) | soybean meat containing large quantity of conjugated linoleic acid and isoflavone and manufacturing method thereof |
Non-Patent Citations (1)
Title |
---|
경남과학기술대학교 대학원, 학위논문(2014년 공지)에 게재된 '송이버섯 균사체를 이용한 콩 고체발효 중 phytoestrogen의 변화' * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200013327A (en) * | 2018-07-30 | 2020-02-07 | 대구한의대학교산학협력단 | Food composition for anti-oxidant and anti-inflammatory comprising extract of fermented soybean and preparation method thereof |
KR20200060000A (en) * | 2018-11-22 | 2020-05-29 | 우석대학교 산학협력단 | Fermented soybean milk food with sprouted bean and process for preparing the same |
KR20200091788A (en) * | 2019-10-24 | 2020-07-31 | 허서진 | Method for preparing powder of mycelium using mushroom medium and grain fermentation powder |
KR20220051584A (en) * | 2020-10-19 | 2022-04-26 | 경상국립대학교산학협력단 | Fermentation composition of mountain-cultivated ginseng having increased ginsenoside Rd, Rc and Protopanaxadiol by using Tricholoma matsutake mycelium and preparation method thereof |
WO2022091089A1 (en) * | 2020-10-28 | 2022-05-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Food products comprising fungal mycelium, process for their preparation and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
KR101993777B1 (en) | 2019-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101993777B1 (en) | Solid fermented soybean with mushroom and method for preparation thereof | |
KR101652035B1 (en) | Method for production of fungi mycelia complex with Inonotus obliquus, Phellinus linteus and parassis Crispa | |
KR101793123B1 (en) | preparing method of fermented soybean enhancing physiological active substance and the physiological active substance thereby | |
KR101889596B1 (en) | Composition of mixed grains fermented with Tricholoma matsutake mycelium having excellent flavor and enhanced functionality, and preparation method thereof and use thereof in food industry | |
KR101901268B1 (en) | Mushroom-fermented soybean using mushroom mycelium and method for manufacturing the same | |
KR20180089259A (en) | Its Manufacturing method and Manufacturing for MEJU using Moringa(Moringa oleifera) Extract by Fermentation | |
KR20160016387A (en) | Composition of culture medium for Hericium erinaceum and Method for culture of the Hericium erinaceum having improved antioxidant activity | |
KR20150014014A (en) | Fermented mulberry composition with antioxidant activity and method of preparing the same | |
KR101776511B1 (en) | Antibacterial-listeria composition of culture medium containing chinese juniper berries fermented with lactobacillus plantarum | |
KR20160121807A (en) | Milled grain fermentation by-products as a main component composition and the manufacturing method using this method of manufacturing a fermented food composition and the fermentation | |
Shin | Utilization of soybean as food stuffs in Korea | |
KR20050013900A (en) | Processing and Manufacturing Methods Using Hypha Body of Fungi | |
KR20040063699A (en) | Functional leg bone broth | |
TWI679983B (en) | Poria cocosfermentation products and manufacturing method of the same | |
KR20130075889A (en) | Soybean composition containing conjugated linoleic acid and a fabrication process thereof and food containing it | |
KR101249800B1 (en) | Extract of red bean fermented with monascus species, method for preparing the same and use of the same | |
KR20200013327A (en) | Food composition for anti-oxidant and anti-inflammatory comprising extract of fermented soybean and preparation method thereof | |
KR20040063695A (en) | Functional feed | |
Sowdhanya et al. | Nutritional significance of velvet bean (Mucuna pruriens) and opportunities for its processing into value-added products | |
KR101334412B1 (en) | The method of preparing powder-enzyme using cereal's buds for soybean sauce | |
KR20180089049A (en) | Fermened Aromia Tea and Process for Perparation thereof | |
KR102547999B1 (en) | Method for manufacturing fermented product enhanced free amino acid content comprising multi-stage fermentation of soybean by-products | |
KR102675146B1 (en) | Mushroom porridge manufacturing method using bean curd and mushroom porridge prepared thereby | |
KR101784136B1 (en) | Mushroom with increased vitamin C content and medium composition for cultivating the mushroom | |
KR20190095914A (en) | Soy bean sauce using essentially acorn powder and manufacturing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right |